Color code:
Privately held
Publicly traded (stock ticker symbol)
Acquired, subsidiary, nonprofit, or dissolved (therefore not counted as a separate genomics firm)

Note: This table is usually updated weekly or biweekly, but is undergoing a major update and will not be revised regularly until sometime in October 2002

Updated 27 August 2002

*Patents in DNA Patent Database (www.genomic.org) through Dec 31, 1999 (in all cases), or when entry updated (see final column).

For listing by public v. private ownership and country of origin (this file updated to 10 June 2001)

 

Firm Name

Website

Public or private?

Address1

Address2

City

State

PostalCode

Country

Phone

Fax

PrimaryContact

Email

Founding year

Firm Type

Patents*

Special terms for  patent search

Other Comments

Date entry modified

  1.  

Qiagen Genomics

www.qiagengenomics.com

Subsidiary of Qiagen

1725 220th Street SE

Suite 104

Bothell

WA

98021

USA

425-398-3140

425-398-3150

Andreas Dusterhoft, Director R&D Genomic Services

a.duesterhoeft@de.qiagen.com

   

6

Patents for Qiagen GmbH (parent company)

   
  1.  

PPD Discovery

www.ppddiscovery.com

Subsidiary of PPD Inc (PPDI)

1505 B. O’Brien Dr.

 

Menlo Park

CA

94025

USA

650.617.2033

650.617.9574

Fred Eshelman, CEO

     

0

Susidiary of PPD, Inc.

   
  1.  

MDS Proteomics Inc

www.mdsintl.com/pharma/default.htm

Subsidiary of MDS Corp.

75 Internatoinal Boulevard

 

Toronto

 

M9W6L6

Canada

416-213-4194 or 800-382-4124

416-213-4199

Ian Lennox, President and CEO of Drug Discovery and Development Sector

     

0

 

Subsidiary of MDS Corp; formed new CRO 3/01

 
  1.  

Callida Genomics Inc.

www.hyseq.com/content/131.php

Subsidiary of Hyseq; collaboration with Affymetrix

               

George Rathman, Interim President and CEO

 

2001

INSTRMT, DNASEQ

 

Assigned Hyseq sequence-by-hybridization patents; see Hyseq.  Owned 90% Hyseq, 10% Affymetrix.

 

8aug02

5.         

RNAture

www.rnature.com

Subsidiary of Hitachi

1003 Health Sciences Road West

 

Irvine

CA

92612-3054

USA

877-327-8762

949-725-2743

949-725-2788

Masato Mitsuhashi, President and CEO

Info@rnature.com

   

0

Wholly owned subsidiary of Hitachi Chemical

   
  1.  

Expression Analysis

www.asciences.com

Subsidiary of Analytical Sciences Inc.

2605 Meridian Parkway

Suite 200

Durham

NC

27713

USA

(919) 544-8500

(919) 544-7507

Laura Reid, chief of genomic sciences

info@asciences.com

   

0

     
  1.  

Toyobo Tsuruga Gene Analysis Laboratory

http://www.toyobo.co.jp/e/rd/kt/index.htm#content

Subsidiary

10-24, Toyo-cho

 

Tsuruga

 

914-0047

Japan

81-770-22-7643

81-770-22-7671

       

0

 

Genetic testing and contract sequencing; subsidiary of Toyoba

 
  1.  

Arradial Inc.

www.alexionpharm.com

Started by Alexion, a publicly traded firm

   

Boston

MA

 

USA

617-241-5794

 

P. Thomas Vogel, President and CEO

 

2000

 

0

 

Started by Alexion Pharmaceuticals

 

9.         

EXACT Sciences Corp

www.exactsciences.com

Publicly tranded (EXAS)

63 Great Road

 

Maynard

MA

01754

USA

978-897-2800

978-897-3481

Don M. Hardison,

President and CEO

dhardison@exactsciences.com

   

7

10 patents listed as of February 2000; formerly Exact Laboratories, Inc.; IPO Feb 2001

   
  1.  

Pharsight Corp.

www.pharsight.com

Publicly traded; subsidiary

NASDAQ: PHST

11230 Sorrento Valley Road

Suite 140

San Diego

CA

02121

USA

858-625-1343

650-314-3889 Mtn View

858-597-1353

Janice H. Kurth, VP Genomics

Jkurth@pharsight.com

2000

 

0

 

Pharsight mainly a clinical research management firm; genomics branch started 2000

 
  1.  

LJL Biosystems Inc.

www.ljlbio.com

Publicly traded, now part of Molecular Devices

(MDCC)

404 Tasman Drive

 

Sunnyvale

CA

94089

USA

(888)611-4555

(408)541-8786

Lev Leytes, Chairman, President and CEO

     

0

 

Acquired by Molecular Devices Corp. July 2000

 
  1.  

CRS Robotics Corp.

www.crsrobotics.com

Publicly traded on Toronto SE

(ROB)

5344 John Lucas Drive

 

Burlington

Ontario

L7L 6A6

Canada

(905) 332-2000

800-365-7587

(905) 332-1114

Ralph Steedman, President and CEO

     

0

     
  1.  

Inex Pharmaceuticals

www.inexpharm.com

Publicly traded on Toronto Exchange

(IEX)

100-8900 Glenlyon Parkway

Glenlyon Business Park

Burnaby

BC

V5J 5J*

Canada

604-419-3200

604-419-3201

David J. Main, President and CEO

Info@inexpharm.com

   

2

     
  1.  

Life Technologies Inc.

www.lifetech.com

Publicly traded on OTC (acquired)

PO Box 6482

 

Rockville

MD

20849-6482

USA

301-840-8000

301-670-1394

J. Stark Thompson, President and CEO

     

58

 

Being acquired by Invitrogen; deal to be complete in 2000.

 
  1.  

Genetic Vectors Inc.

www.gvec.com

Publicly traded on OTC

(GVEC)

5201 NW 77th Avenue

Suite 100

Miami

FL

33166

USA

305-716-0000

305-716-0001

Mead McCabe, Jr., CEO

Info@gvec.com

   

0

Acquired DNA Sciences, Inc (of San Diego, different from DNA Sciences, Inc above) 2/2000

   
  1.  

GeneScan Europe AG

www.biochip.com

Publicly traded on Neuer Market (GEP)

Engesserstr. 4 b

79108

Freiburg

   

Germany

0761-5038-0

0761-5038-111

Ulrich Birsner, CEO

     

0

12 subsidiary companies; no DPD patents for BioChip, GeneScan, or BioRobotics, but refers to a “large patent portfolio at its disposal” and several pending patents on its website. 2000 annual report states 23 patents for 2000, none by 1999.

   
  1.  

MorphoSys GmbH

www.morphosys.de

Publicly traded on Neuer exchange

(MOR)

Lena-Christ-Straße 48

D- 82152

Martinsreid/Munich

   

Germany

49 (0)89 89927 0

49 (0)89 89927 222

Simon E. Moroney, CEO

Info@morphosys.de

   

1

     
  1.  

Oxford GlycoSciences plc

www.ogs.com

Publicly traded on London Exchange (OGSI; OGS)

2 The Quadrant, Barton Lane

Abingdon Science Park

Abingdon

Oxon

OX16 3J

UK

(44)1235-543200

(44)1235-554701

David Ebsworth, CEO

michael.kranda@ogs.co.uk

   

5

(Patents for Oxford gene systems =3, Oxford technologies 1, Oxford biomedica 1; See also ISIS Innovation with 7 patents)

   
  1.  

Pharmagene PLC

www.pharmagene.com

Publicly traded on London Exchange

(PGN)

Orchard Road

Royston

Hertfordshire

 

SG8 5HD

UK

44 0-1763 211 600

44-1-1763-211 630

Alastair Riddell, CEO

Alastair.riddell@pharmagene.com

   

0

 

IPO 7/2000

 
  1.  

Molecular Devices Corp.

www.moleculardevices.com

Publicly traded NASDAQ: (MDCC)

1311 Orleans Drive

 

Sunnyvale

CA

94089

USA

800-635-5577

 

Joseph D. Keegan, President and CEO

 

2000

 

0

 

Merger of LJL BioSystems July 2000

 
  1.  

Zymogenetics

www.zymogenetics.com

Publicly traded (ZGEN)

1201 Eastlake Avenue East

 

Seattle

WA

98102-3702

USA

206-442-6600

206-442-6608

Bruce L. A. Carter, President and CEO

Info@ngi.com

   

80

 

Established as US discovery arm of Novo Nordisk;separate company 2000, IPO Feb 2002

 
  1.  

Valentis Inc.

www.valentis.com

Publicly traded (VLTS)

863A Mitten Road

 

Burlingame

CA

94010

USA

650.697.1900

650.652.1990

Banjamin F. McGraw, President and CEO

info@Valentis.com

Ben@valentis.com CEO

   

4

Website lists 58 Issued US patents 2/15/01

Formed from merger of PolyMASC, GeneMedicine, and Megabios

 
  1.  

Sigma Genysys

www.genosys.com

Publicly traded (subsidiary, not included in R&D or market cap figures)

1442 Lake Front Circle

 

The Woodlands

TX

77380

USA

800-234-5DNA

281-363-2693

 

Ginformation@sial.com

   

0

 

Subsidiary of Sigma Aldrich {not included among publicly traded genomics firms due to small fraction of genomics business)

 
  1.  

Sangamo  Biosciences Inc.

www.sangamo.com

Publicly traded (SGMO)

501 Canal Boulevard

 

Richmond

CA

94804

USA

510-970-6000

510-236-8951

Edward O. Lanphier, President and CEO

Lanphier@sangamo.com

   

0

 

Acquired Gendaq June 2001

 
  1.  

Rosetta Inpharmatics

www.rii.com

Publicly traded (RSTA).  Acquired by Merck (not included in figures and tables)

12040-115th Avenue NE

 

Kirkland

WA

98034

USA

425-820-8900

425-821-5354

Stephen Friend, President and CSO

     

1

 

IPO August 8, 2000; Acquisition by Merck & Co. announced May 11, 2001.

 
  1.  

Paradigm Genetics

www.paradigmgenetics.com

Publicly traded (PDGM)

104 Alexander Drive, Building 2

PO Box 14528

Research Triangle Park

NC

27709-4528

USA

919-425-3000

919-544-8094

Heinrich Gugger, President and CEO

pr@paradigmgenetics.com

1997

GENEFNL, GENEXPR, AGRIVET

2

   

27jul02

27.      

Pharmacopeia

www.pcop.com

Publicly traded (PCOP)

3000 Eastpark Boulevard

 

Cranbury

NJ

08512

USA

609 452 3600

609 452 3672

Joseph A. Mollica, President and CEO

info@pharmacopeia.com

   

4

Owns Accelrys, which acquired Synomics June 2001; acquired Eos Aug 2001.

   
  1.  

Genetix

www.genetix.co.uk

Publicly traded (GTX.L) on FTSE

Queensway

New Milton

 

Hampshire

BH25 5NN

UK

01-425-624-600

01-425-624700

Mark Reid, CEO

     

0

 

Acquired Genpak Ltd. IPO November 2000

 
  1.  

Ecopia Biosciences Inc.

www.ecopiabio.com

Publicly traded (EIA TorontoSE)

7290 Frederick-Banting

 

Saint-Laurent

Québec

 

Canada

(514) 336-2700

(514) 336-8827

Eric A. Cohen, Chairman and CEO

nowacki@ecopiabio.com

   

0

     

30.      

Epoch Biosciences

www.epochbio.com

Publicly traded (EBIO)

21720 - 23rd Dr. SE

Suite 150

Bothell

WA

98021

USA

425.482.5555

425.482.5550

Bill Gerber, CEO

dwalburger@epochbio.com

   

10

Includes patents for Epoch Pharmaceuticals, Bothell and Redmond, WA

   

31.      

AVI BioPharma

www.avibio.com

Publicly traded (AVII; AVIIW; AVIIZ)

One SW Columbia Street

Suite 1105

Portland

OR

97258

USA

503-227-0554

503-227-0751

Denis R. Burger, CEO

Avi@avibio.com

   

1

Assigned to AntiVirals Inc. (former name)

Also licensed 11 patents from Ohio State Univ, 16 from Univ Nebraska

   
  1.  

Autogen Limited

www.autogenlimited.com.au

Publicly traded (ATG Australian Stock Exchange)

210 Kings Way

 

South Melbourne

Victoria

3205

Australia

61 3 9234 1188

03 9234 1188 or 0419 897 501

61 3 9234 1198

Greg Collier, Chief Scientific Officer

autogen@awi.com.au

   

0

     
  1.  

Array BioPharma

www.arraybiopharma.com

Publicly traded (ARRY)

1885 33rd Street

 

Boulder

CO

80301

USA

303-381-6600

303-449-5376

Robert E. Conway, CEO

     

0

 

IPO Nov 2000

 
  1.  

Genetic Technologies Ltd.

www.gtg.com.au

Publicly traded

(GTG ASX)

60-66 Hanover Street

 

Fitzfory

Victoria

3065

Australia

3.9415.1135

3.9417.2987

Mervyn Jacobson, Executive Chairman

info@gtg.com.au

   

5

Acquired GeneType AG (Zug, Switzerland) Aug 2000.  Patents held by Gene Type.  Website lists 7 US Patents licensed to GTG.

   

35.      

Chondrogene Inc.

www.chondrogene.com

Publicly traded

(YDG on Canadian Venture Exchange)

800 Petrolia Road

Unit No. 15

Toronto

Ontario

 

Canada

(416) 650-0060

(416) 650-0055

David E Caspari, President and CEO

decaspari@chondrogene.com

   

0

     
  1.  

Genomics One Corporation

www.genomicsone.com

Publicly traded

on Montreal Eschange (GNX)

3030 Le Carrefour Blvd.

Suite 902

Laval

Quebec

H7T 2P5

Canada

(877)684-3637

(450)688-4499

 

Dr. Suzanne Lebel, President

slebel@genomicsOne.com

   

0

     
  1.  

SignalGene Inc.

www.signalgene.com

Publicly traded

(SGI)

8475 Christophe-Colomb Avenue

Suite 1000

Montreal

Quebec

H2M 2N9

Canada

(514)850-2400

(514)850-2424

George Masters, Interim President and CEO

Michael.dennis@signalgene.com

   

0

     
  1.  

Tm Bioscience Corp.

www.tmbioscience.com

Publicly traded

(CDNX: TMC)

439 University Ave.

11th Floor

Toronto

Ontario

 

Canada

(416) 593-4323

(416) 593-1066

Gregory C. Hines, President & CEO

info@tmbioscience.com

   

0

     

39.      

Azign Bioscience A/S

www.azign.com

Publicly traded

NeuroSearch AS

(NEUS.CO)

Vestre Teglgade 10

 

Copenhagen

 

DK-2450

Denmark

45 70 22 22 02

45 70 23 23 04

 

info@azign.com

   

0

 

Formed with merger of NeuroSearch AS acquisition of  Display Systems Biotech AS

www.neurosearch.com

 
  1.  

LION BioScience AG

www.lionbioscience.com

Publicly traded

(LEON)

Im Neuenheimer Feld 517

 

Heidelberg

 

D 69120

Germany

49-6221-403-823

49-6221-403-835

Friedrich von Bohlen, CEO

     

0

 

IPO July 10, 2000

 
  1.  

deCODE Genetics

www.decode.is

Publicly traded

(DCGN)

Lynghalsi 1

 

Rekjavik

 

IS-100

Iceland

354-577-1900

354-577-1901

Kari Stefansson, President and CEO

Kstefans@decode.is

   

0

MediChem also

IPO July 2000; acquired MediChem March 2002

 
  1.  

Keryx Biopharmaceuticals Inc.

www.keryxbiopharm.com

Publicly traded

(KERX)

Kiryat Mada 5

Har Hotzvim

Jerusalem

 

91326

Israel

972-2-541-2700

972-2-541-2701

Morris Laster, CEO

     

0

 

IPO June 2000

 
  1.  

Biacore AB

www.biacore.com

Publicly traded

(BCOR)

Radsgatan

SE-754 50

Uppsala

   

Sweden

46 18 675700

46 18 150110

Ulf Jonsson, President

Develop-bia@biacore.com

   

2

     
  1.  

Pyrosequencing AB

www.pyrosequencing.com

Publicly traded

(PYRO A: Stockholm)

SE-752

 

Uppsala

 

28

Sweden

46-18-565-900

46-18-516000

Erik Wallden, President and CEO

Info@pyrosequencing.com

   

0

     
  1.  

Cytomyx

www.cytomyx.com

Publicly traded

(EPIC-CYX) on AIM

140 Science Park

 

Cambridge

 

CB4 0GF

UK

44-1223-508191

44-1223-508198

 

Info@cytomyx.com

   

0

 

Formerly Cambridge BioScience

 
  1.  

Gemini Genomics Ltd.

www.gemini-genomics.com

Publicly traded

(GMNI) being acquired by Sequenom

162 Science Park

 

Cambridge

 

CB4 0GH

UK

44-0-1223-435300

44 1223 435339

44-0-1223-435301

Paul Kelly, CEO

Paul.kelly@gemini-genomics.com

   

2

 

IPO July 2000; announced acquisition by Sequenom May 2001 completed Q3 2001.

 
  1.  

Abgenix

www.abgenix.com

Publicly traded

(ABGX)

7601 Dumbarton Circle

 

Fremont

CA

94555

USA

(510)608-6500

(510)608-6589

R. Scott Greer, Chairman, President and CEO; Raymond Withy to become CEO mid-2002

     

4

     
  1.  

Aclara Biosciences Inc.

www.aclara.com

Publicly traded

(ACLA)

1288 Pear Avenue

 

Mountain View

CA

94034

USA

650-210-1200

 

Joseph M. Limber, President and CEO

Jlimber@aclara.com

   

0

     
  1.  

Affymetrix Inc.

www.affymetrix.com

Publicly traded

(AFFX)

3380 Central Expressway

 

Santa Clara

CA

95051

USA

(408)731-5000

(408)481-0422

Stephen Fodor, CEO

     

25

     
  1.  

Applied Biosystems

www.appliedbiosystems.com

Publicly traded

(ABI)

850 Lincoln Centre Drive

 

Foster City

CA

94404

USA

650-638-5800

800-345-5224

650-638-5884

Michael Hunkapiller, President

     

27

Includes PerSeptive Biosystems patents (4);, Boston Probes; PNA Diagnostics

Name reverted to Applied Biosystems July 2000 (was PE Biosystems 1997-2000)

 
  1.  

Applied Molecular Evolution Inc.

www.AMEvolution.com

Publicly traded

(AMEV)

3520 Dunhill Street

 

San Diego

CA

92121

USA

858-597-4990

858-597-4950

William D. Huse

Lblock@amevolution.com

   

6

Formerly Ixsys (includes Ixsys patents)

IPO July 2000

 
  1.  

ARIAD Pharmaceuticals Inc.

www.ariad.com

Publicly traded

(ARIA)

26 Landsdowne Street

 

Cambridge

MA

02139

USA

(617)494-0400

(617)494-8144

Harvey J. Berger, Chairman and CEO

     

1

     
  1.  

Aurora Biosciences Corp.

www.aurorabio.com

Publicly traded

(ABSC).  Acquired by Vertex.

11010 Torreyana Road

 

San Diego

CA

92121

USA

(619)404-6600

(619)404-6714

Michael Wokasch, President, Chairman, and CEO

     

5

3 for Aurora; 2 for PanVera, which was acquired by Aurora in Feb 2001

Aurora acquired by Vertex July 2001

 
  1.  

AxyS Pharmaceuticals Inc.

www.axyspharm.com

Publicly traded

(AXPH). Acquired by Celera.

180 Kimball Way

 

South San Francisco

CA

94080

USA

(650)829-1000

(650)829-1001

John P. Walker, Chairman and CEO

     

5

(Patents include Sequana [former name for Axyxs]). 

Celera announced acquisition of Axys 13 June 2001; approved Nov 2001.

 
  1.  

Bruker Daltonics

www.brukerdaltonics.com

Publicly traded

(BDAL)

15 Fortune Drive

 

Billerica

MA

01821

USA

978-663-3660

978-667-5993

Frank H. Laukien, President and CEO

info@daltonics.bruker.com

   

2

Patents assigned to parent company in Germany; IPO Aug 2000

   
  1.  

Caliper Techologies Corp.

www.calipertech.com

Publicly traded

(CALP)

605 Fairchild Drive

 

Mountain View

CA

94043-2324

USA

650-623-0700

650-623-0500

Daniel L. Kisner, CEO and President

Info@calipertech.com

   

3

1999 annual report states the company owns 52 patents (DPD count to left contains only DNA-based patents).  Most Caliper patents are in microfluidics

   
  1.  

Celera Genomics

www.celera.com

Publicly traded

(CRA)

45 West Gude Drive

 

Rockville

MD

20850

USA

(877)CELERA1

240-453-3000

(240)453-4000

Kathy Ordoñez, President

webadmin@celera.com

   

5

Celera had no patents, but acquired Axys (formerly Sequana) in June 2001.  (Patents for Perken-Elmer, Applied Biosystems, PerSeptive Biosystems or PE Corp. = 63)

   
  1.  

Cepheid

www.cepheid.com

Publicly traded

(CPHD)

1190 Borregas Avenue

 

Sunnyvale

CA

94089-1302

USA

408-541-4191

408-541-4192

John L. Bishop, CEO

     

0

     
  1.  

Ciphergen Biosystems

www.ciphergen.com

Publicly traded

(CIPH)

6611 Dumbarton Circle

 

Freemont

CA

94555

USA

510-505-2100

510-505-2101

William E. Rich, President and CEO

     

0

 

IPO Sept 2000

 
  1.  

Corixa

www.corixa.com

Publicly traded

(CRXA)

1124 Columbia Street

Suite 200

Seattle

WA

98104-2040

USA

206-754-5711

206-754-5715

Steven Gillis, Chairman and CEO

Info@corixa.com

   

4

     
  1.  

CuraGen Corp.

www.curagen.com

Publicly traded

(CRGN)

555 Long Wharf Drive

11th floor

New Haven

CT

06511

USA

(888)GENOMICS

203-401-3331

Jonathan M. Rothberg, CEO

     

3

     
  1.  

Deltagen

www.deltagen.com

Publicly traded

(DGEN)

1003 Hamilton Court

 

Menlo Park

CA

94025

USA

650-752-0200

650-752-0208

650-752-0202

William Matthews, CEO

Michael Sember, President and COO

Matthews@deltagen.com

   

4

 

IPO Aug 2000; Acquired Arcaris (and its 4 DPD patents) July 2001.

 
  1.  

Digene Inc

www.digene.com

Publicly traded

(DIGE); to be acquired by Cytyc

1201 Clopper Road

 

Gaithersburg

MD

20878

USA

800-344-3631

301-944-7000

301-944-7121

Evan Jones, President and CEO

inforeq@digene.com

   

7

5 patents through 1999; 2 patents 2000; Cytyc to purchase Digene, April 2002

   

64.      

Discovery Partners International

www.discoverypartners.com

Publicly traded

(DPII)

9640 Towne Centre Drive

 

San Diego

CA

92121

USA

858-455-8600

858-546-3081

Ricardo Pigliucci, President and CEO

Email via website

   

3

     
  1.  

Diversa Corp.

www.diversa.com

Publicly traded

(DVSA)

10665 Sorrento Valley Road

 

San Diego

CA

92121

USA

619-453-7020

619-453-7032

Terrance Bruggamen, Chairman and CEO

     

20

     
  1.  

DNAPrint Genomics

www.dnaprint.com

Publicly traded

900 Cocoanut Avenue

 

Sarasota

FL

34236

USA

941-366-3400

941-952-9770

Anthony Frudakis, CEO and President

admin@dnaprint.com

2000

DNATest, dnaseqn, infrmtx

0

Does not have patents assigned to the firm; website lists 8 patent applications and notes the the President and CEO holds 7 patents that cover 350 genes and 2 products

Was acquired by previously bankrupt CYTC; Catalyst Communications and began gene testing

27aug02

  1.  

Exelixis Pharmaceuticals Inc.

www.exelixis.com

Publicly traded

(EXEL)

260 Littlefiled Ave.

 

South San Francisco

CA

94080

USA

650-825-2200

650-825-2205

George Scangos, President and CEO

     

0

Website notes 2 patents, but not contained in DPD through Dec ’99; announced acquisition of Genomica Corp. Nov 2001.

   

68.      

Genaera

www.genaera.com

Publicly traded

(GENR)

5110 Campus Drive

 

Plymouth Meeting

PA

19462

USA

(610) 941-4020

(610) 941-5399

Roy C. Levitt, President and CEO

Info@genaera.com

   

4

Former name Magainin (to which name patents are assigned)

Formerly Magainin

 
  1.  

Genaissance Pharmaceuticals Inc.

www.genaissance.com

Publicly traded

(GNSC)

5 Science Park

 

New Haven

CT

06511

USA

203-773-1450

203-562-9377

Gualberto Ruano, CEO and President

     

1

     
  1.  

Gene Logic Inc.

www.genelogic.com

Publicly traded

(GLGC)

708 Quince Orchard Road

 

Gaithersburg

MD

20878

USA

(301)987-1700

(301)987-1701

Mark D. Gessler, President and COO

     

3

(Patents include Oncormed, purchased 12/98)

   
  1.  

GeneLink Inc.

www.bankdna.com

Publicly traded

(GNLK)

PO Box 3212

 

Margate

NJ

08402

USA

800.558.4363

609-823-6991

 

John R. DePhillipo,  President and CEO

genelink@aol.com

   

0

Website notes new patent 6,291,171 (25 Oct 2000) not in DPD; two other patents pending as of Jan 2002.

   
  1.  

Genome Therapeutics Corp.

www.cric.com or

www.genomecorp.com

Publicly traded

(GENE)

100 Beaver Street

 

Waltham

MA

02453-8443

USA

(781)398-2300

(781)893-9535 or -8277

Robert J. Hennessey, President, Chairman, and CEO; Bernard Seizinger, CSO

Robert.Hennessey@genomecorp.com

   

8

Patents include from Collaborative Research Labs

   
  1.  

Genomica Corporation

www.genomica.com

Publicly traded

(GNOM); acquired by Exelixis

4001 Discovery Drive

Suite 130

Boulder

CO

80303

USA

(303)402-9800

(303)402-9877

James Clemens, VP of Development

Clemens@genomica.com

   

0

 

IPO 28 Sept 2000; acquisition by by Exelixis announced Nov 2001

 
  1.  

Global Genomics Inc.

www.cytrx.com

Publicly traded

(CYTR)

11726 San Vicente Blvd.

Suite 650

Los Angeles

CA

90049

USA

310.826.5648

310.826.6139

Steven A Kriegsman, President and CEO

reynoldm@cytrx.com

2002

GENEFNL, AGRIVET, TRSTFND, DRUGDEV

0

CytRx and Global Genomics Capital

Formed from May 2002 merger of CytRx and Global Genomics Capita; owns 40% of Blizzard Genomics and 5% of Psynomicsl

27jul02

  1.  

Harvard Biosciences

www.harvardbioscience.com

Publicly traded

(HBIO)

84 October Hill Road

 

Holliston

MA

01746

USA

508.893-8999

800.272.2775

508.429.5732

Chane Graziano, CEO

bioscience@harvardapparatus.com

1901; entered genomics 2002

INSTRMT, SUPPLYR

1

Genome Solutions patent

Acquired Genomic Solutions July 2002

27jul02

  1.  

Human Genome Sciences Inc.

www.hgsi.com

Publicly traded

(HGSI)

9410 Key West Avenue

 

Rockville

MD

20850

USA

(301)309-8504

(301)309-8512

William Haseltine, President

     

106

(128 patents through 6/12/2000)

   
  1.  

Hyseq Inc.

www.hyseq.com

Publicly traded

(HYSQ)

675 Almanor Avenue

 

Sunnyvale

CA

94086

USA

(408)524-8100

(408)524-8117

Ted. W. Love, CEO

ir@hyseq.com

1992

INSTRMT, DNASEQ

14

Callida and N-Mer are subsidiaries.

 

8aug02

  1.  

Illumina Inc.

www.illumina.com

Publicly traded

(ILMN)

9390 Towne Centre Drive

Suite 200

San Diego

CA

92121

USA

(858) 587-4290

(858)587-4233

(858) 587-4297

Jay Flatley, President and CEO

jflatley@illumina.com

1998

INSTRMT, GENEXPR, SUPPLYR

0

   

27jul02

  1.  

Incyte Genomics Inc.

www.incyte.com

Publicly traded

(INCY)

3160 Porter Drive

 

Palo Alto

CA

94304-1203

USA

(650)855-0555

(650)855-0572

Paul A. Friedman, CEO

webmaster@incyte.com

   

276

(474 patents through 6/12/2000)

   
  1.  

InforMax Inc.

www.informaxinc.com

Publicly traded

(INMX)

6010 Executive Boulevard

10th floor

North Bethesda

MD

20852

USA

240-223-0100

301-984-2206

240-223-3201

Andrew Whiteley, President, Chairman, and CEO

     

0

 

IPO 28 Sept 2000

 
  1.  

Insightful Inc.

www.insightful.com

Publicly traded

(IFUL)

1700 Westlake North

Suite 500

Seattle

WA

98109-3044

USA

206.283.8802

 

Shawn Javid, President and CEO

thart@insightful.com

   

0

 

Data mining (genomics only small part of business); NIH SBIR award July 2002; R&D figures reported p. 22 of 2001 annual report (‘news’ on website)

 
  1.  

Invitrogen Inc.

www.invitrogen.com

Publicly traded

(IVGN)

1600 Faraday Avenue

 

Carlsbad

CA

92008

USA

800-955-6288

760-603-7201

Lyle C. Turner, Chairman and CEO

     

2

 

Purchasing Life Technologies; deal to close by end of 2000.

 
  1.  

Large Scale Biology (and Proteomics)

www.lsbc.com

Publicly traded

(LSBC)

3333 Vaca Valley Pkwy

Suite 1000

Vacaville

CA

95688

USA

707-446-5501

707-446-3917

Robert L. Erwin, President and CEO

     

17

BioSource Technologies purchased and changed names to Large Scale Biology 1999 (count includes both Cos.); IPO Aug 2000

   
  1.  

Lexicon Genetics Incorporated

www.lexicon-genetics.com see also

www.lexgen.com

Publicly traded

(LEXG)

4000 Research Forest Drive

 

The Woodlands

TX

77381-4287

USA

(281)364-0100

(281)364-0155

Arthur Sands, President and CEO

jgregory@lexgen.com

   

0

 

Knockout mouse initiative through Merck Genome Research Institute

 
  1.  

Lynx Therapeutics Inc.

www.lynxgen.com

Publicly traded

(LYNX)

25861 Industrial Blvd.

 

Hayward

CA

94545

USA

(510)670-9300

(510)670-9302

Kevin Corcoran, President and CEO

     

27

     
  1.  

Magainin Pharmaceuticals Inc.

www.magainin.com

Publicly traded

(MAGN). Name changed (don’t include in tables and figures)

5110 Campus Drive

 

Plymouth Meeting

PA

19462

USA

610-941-4020

(610) 941-5399

Michael R. Dougherty, President and CEO

Info@magainin.com

   

4

Name changed to Genaera (see above)

   
  1.  

Maxygen Inc.

www.maxygen.com

Publicly traded

(MAXY)

515 Galveston Drive

 

Redwood City

CA

94063

USA

650-298-5300

650-364-2715

William P. C. Stemmer, Vice President for Research

     

1

     
  1.  

Millennium Pharmaceuticals Inc.

www.mlnm.com

Publicly traded

(MLNM)

75 Sidney Street

 

Cambridge

MA

02139

USA

(617)679-7000

617-679-7219 CEO

(617)374-9379

##Steven H. Holtzman, Chief Business Officer

holtzman@mpi.com

   

161

(Includespatents for “Millenium” and “Milennium” misspelled)

   
  1.  

Myriad Genetics Inc.

www.myriad.com

Publicly traded

(MYGN)

320 Wakara Way

 

Salt Lake City

UT

84108

USA

(801)584-3600

(801)584-3640

Mark Skolnick, CSO

     

16

     
  1.  

Onyx Pharmaceuticals Inc.

www.onyx-pharm.com

Publicly traded

(ONXX)

3031 Research Drive

 

Richmond

CA

94806

USA

(510)222-9700

(510)222-9758

Allan Balmain, VP for Research

     

13

     
  1.  

Orchid BioSciences Inc.

www.orchidbio.com

or www.orchid.com

Publicly traded

(ORCH)

303 College Road East

 

Princeton

NJ

08540

USA

609-750-2200

609-750-2250

Dale Pfost, President an CEO

     

11

Started as Orchid Biocomputers Inc.; Acquired LifeCodes Oct 2001 (4 Orchid patents, 7 Lifecodes patents).

   
  1.  

OSI Pharmaceuticals

www.osip.com

Publicly traded

(OSIP)

777 Old Saw Mill River Road

 

Tarrytown

NY

10591-6705

USA

914-467-6200

ext 314 CEO; (Corp HQ in Uniondale 516-222-0023)

516-222-0114

Benjamin Benton, Head of Functional Genomics

Bbenton@osip.com

   

0

     
  1.  

Packard Bioscience

www.packardbioscience.com

Publicly traded

(PBSC)

800 Research Parkway

 

Meriden

CT

06450

USA

203-238-2351

800-243-4422

201-329-8660

 

Emery G. Olcott, CEO

Mpassavant@packardbioscience.com

   

1

     
  1.  

Pathogenesis Corp..

www.pathogenesis.com

Publicly traded

(PGNS)

201 Elliott Avenue West

 

Seattle

WA

98119

USA

206-467-8100

206-270-313

Wilbur H. Gantz, Chairman and CEO

     

3

     
  1.  

Protein Design Labs

www.pdl.com

Publicly traded

(PDLI)

34801 Campus Drive

 

Fremont

CA

94555-3606

USA

(650)903-3700

(650)903-3730

Douglas O. Ebersole, Interim CEO

     

7

     
  1.  

Rigel Inc.

www.rigel.com

Publicly traded

(RIGL)

240 E. Grand Avenue

 

South San Francisco

CA

94080

USA

650-624-1100

650-624-1101

James Gower, President and CEO

     

0

 

IPO 11/28/00

 
  1.  

Seattle Genetics Inc.

www.seattlegenetics.com

Publicly traded

(SGEN)

22215 26th Avenue SE

Suite 3000

Bothell

WA

98021

USA

425-489-4990

425-489-4798

H. Perry Fell, CEO

     

0

Licenses to patents from CEO and CSO

IPO Mar 2001

 
  1.  

Sequenom Inc.

www.sequenom.com

Publicly traded

(SQNM)

11555 Sorrento Valley Road

 

San Diego

CA

92121-1331

USA

858-350-0345

858-350-0344

Hubert Koster, President and CEO

     

8

6 Sequenom + 2 Gemini Genomics; announced acquisition of Gemini May 2001.  Total of 11 issued gene patents and 89 pending; 59 issued or allowed technology patents with 96 pending between the two companies as of May 2001.

   
  1.  

Targeted Genetics Corp.

www.targen.com

Publicly traded

(TGEN)

1100 Olive Way

Suite 100

Seattle

WA

98101

USA

206-623-7612

206-623-0288

H. Stewart Parker, President and CEO

     

3

     
  1.  

Third Wave Technologies Inc.

www.twt.com

Publicly traded

(TWTI)

502 South Rosa Road

 

Madison

WI

53719

USA

888-898-2357

608-273-8933

608-273-8618

Lance Fors, CEO

     

12

 

Plan for acquisition by PE Biosystems announced 1/24/2000.  Merger canceled 5/2000.  IPO announced, delayed; occurred Feb 2001.

 
  1.  

Transgenomic Inc.

www.transgenomic.com

Publicly traded

(TBIO)

12325 Emmet Street

 

Omaha

NE

68164

USA

(888)233-9283

(402)452-5453

Collin D'Silva, CEO

Info@transgenomic.com

   

16

 

Services Co., IPO 7/2000

 
  1.  

Tripos

www.tripos.com

Publicly traded

(TRPS)

1699 South Hanley Road

 

Saint Louis

MO

63144-2913

USA

314-647-1099 or 800-323-2960

314-6479241

John P. McAlister III, President and CEO

Info@tripos.com

   

0

     
  1.  

Variagenics Inc.

www.variagenics.com

Publicly traded

(VGNX)

60 Hampshire Street

 

Cambridge

MA

02139-1562

USA

617-588-5300

617-588-5399

Jay Mohr, President and CBO

     

0

 

Pharmacogenetics, IPO 7/2000

 
  1.  

Vysis Inc.

www.vysis.com

Publicly traded

(VYSI).  Acquired by Abbott.

3100 Woodcreek Drive

 

Downers Grove

IL

60515-5400

USA

(800)553-7042

(630)271-7138

John L. Bishop, President and CEO

     

4

 

Acquired by Abbott Nov 2001.

 
  1.  

Xenometrix

www.xeno.com

Publicly traded

OTCBB:XENO.OB

2425 North 55th Street

 

Boulder

CO

80301-5700

USA

303-447-1773

303-447-1758

Pauline Gee, President and CEO

Pgee@xeno.com

   

1

Quarterly 10QSB SEC of 2/14/01 also notes EPO patent and “similar patents” but does not further specify them.

Acquired by Discovery Partners Feb 2001 (NASDAQ: DPII)

 
  1.  

Cereon Genomics LLC

www.cereon.com

Privately held. Subsidiary shut down by Monsanto.

45 Sidney Street

 

Cambridge

MA

02139

USA

617-551-8000

617-551-1990

David Fischhoff & Mark Trusheim, co-Presidents

     

0

 

Subsidiary of Pharmacia, formed in partnership betw. Monsanto and Millennium; agricultural genomics.  Shut down by Monsanto April 2002.

 

107.   

CombiMatrix Inc.

www.combimatrix.com

Privately held. Plan for IPO.

6500 Harbor Heights Parkway

 

Mukilteo

WA

98275

USA

425.493.2000

425.493.2010

Amit Kumar, President and CEO

Info@combimatrix.com

1995

Instrmt, genetest

0

 

IPO registration filed Nov 2000; plan to float stock separate from majority owner, Acacia, proposed March 2002; no IPO as of Aug 2002.

27aug02

  1.  

Scriptgen Pharmaceuticals Inc.

www.scriptgen.com

Privately held. Merged to become Anadys.

610 Lincoln Street

 

Waltham

MA

02451-2186

USA

781-768-3400

781-768-0040

Mark Weedon, President and CEO

     

1

 

Merged with Asklepios to form Anadys (see above).

 
  1.  

Genometrix Inc.

www.genometrix.com or

www.mydna.net

Privately held. Ceased operations. Patent rights acquired by High Throughput Genomics.

2700 Research Forest Drive

Suite B7

Woodlands

TX

77381

USA

281-465-5000

281-465-5002

Robert Ellis, CEO (moved to Affymetrix just before Genometrix ceased operations)

     

(0)

 

IPO registerd and withdrawn Spring 2001; ceased operations 25 June 2001; Universal Array patent rights purchased by High Throughput Genomics Feb 2002

27aug02

110.   

Prospect Genomics Inc.

www.prospectgenomics.com

Privately held. Acquired by Structural GenomiX

2618 Belmont Canyon Road

 

Belmont

CA

94002

USA

650-654-3510

650-996-2095

Richard D. Goold, President

     

0

Acquired by Structural GenomiX, April 2001

   
  1.  

NetGenics Inc.

www.netgenics.com

Privately held. Acquired by LION

1717 E. Ninth Street

Suite 1600

Cleveland

OH

44114

USA

216-861-4007

888-861-9007

216-861-4777

Manuel J. Glynias, President and CEO

     

0

 

IPO registered Mar 2000, but put on hold; acquired by LION BioScience Jan 2002

 
  1.  

Mitotix Inc.

www.mitotix.com redirects to: www.gpc-biotech.com

Privately held. Acquired by GPC Biotech

Building 600

Suite 622, One Kendall Square

Cambridge

MA

02139

USA

617-225-0001

617-225-0005

William Helman, Chairman

     

8

 

Purchased by GPC Biotech

 
  1.  

Genomic Medicine Inc.

 

Privately held. Acquired by GenoMed

   

Saint Louis

MO

 

USA

               

Letter of intent to acquire from GenoMed Nov 2001.

 
  1.  

Advanced Array Technology SA

www.AAT-Array.com

Privately held. Acquired by Eppendorf.

rue de Seminaire, 22

B-5000

Namur

   

Belgium

32-81-724151

32-81-725128

Jose Remacle, Director of Biochemistry and Cellular Biology

aatinfo@aat-array.com

1999

INSTRMTN, SUPPLYR

0

 

Univ Namur spinoff; majority acquired by Eppendorf July 2002

27jul02

  1.  

Arcaris Inc.

www.vegen.com

Privately held. Acquired by Deltagen.

615 Arapeen Drive

Suite 300

Salt Lake City

UT

84108

USA

801-303-0300

 

M. Scott Salka, CEO

     

2

 

Acquired by Deltagen July 2001

 
  1.  

Boston Probes

www.bostonprobes.com

Privately held. Acquired by Applied Biosytems.

75E Wiggins Ave.

 

Bedford

MA

01730

USA

781-271-1100

781-276-4931

Jack T. Johansen, CEO

dcicciarella@bostonprobes.com

   

1

 

Acquired by Applied Biosystems, Nov 2001

 
  1.  

Neomorphic Inc.

www.neomorphic.com

Privately held. Acquired by Affymetrix.

2612 8th Street

 

Berkeley

CA

 

USA

510-704-1030

(510) 704-1013

Cyrus Harmon, President and CEO

     

0

 

Acquired by Affymetrix Oct 2000

 
  1.  

Shanghai Genecore BioTechnologies Co. Ltd.

www.genecore.com/eindex.html

Privately held.  Subsidiary of Applera.

Thrid Floor

No. 200

Tian Lin Road

Shanghai

 

China

021-64956278

021-64859746

 

genecore@online.sh.cn

   

0

 

Wholly foreign-owned subsidiary of Applera and Celera Corps.

 
  1.  

Structural Bioinformatics Inc

www.strubix.com

Privately held.  SBI subsidiary.

10929 Technology Place

 

San Diego

CA

92127

USA

858-675-2400

858-451-3828

Edward T. Maggio, President and CEO

emaggio@strubix.com

   

0

 

Subsidiary of SBI Advanced Technologies A/S

 
  1.  

DoubleTwist Inc.

www.doubletwist.com

Privately held.  Ceased operations.

2001 Broadway

 

Oakland

CA

94612

USA

510-628-0100

510-628-0108

Robert Williamson, President and CEO

info-pr@doubletwist.com

   

0

Includes Pangea (former name); ceased operations March 2002

   
  1.  

GenomicFX

www.genomicfx.com

Privately held.  Ceased operations.

12024 Vista Parke Drive

Suite 2250

Austin

TX

78726

USA

512-439-5300

512-439-5275

 

contact@genomicfx.com

       

Announced it would cease operations Aug 2001.  Had acquired Genetic Solutions of Brisbane, Australia (not Genomic Solutions, listed below).

 
  1.  

Gendaq

www.gendaq.com

Privately held.  Acquired by Sangamo.

1-3 Burtonhole Lane

 

London

 

NW7 1AD

UK

44-20-8982-6738

44-20-8982-6748

Timothy Brears, CEO

Pr@gendaq.com

   

0

 

Acquisition by Sangamo Biosciences announced 29 June 2001

 
  1.  

Paracel

www.paracel.com

Privately held.  Acquired by Celera.

80 S. Lake Ave

Suite 650

Pasadena

CA

91101-2616

USA

626-744-2000

626-744-2188 CEO

626-744-2001

Shi-Ping Hsu, VP Technology and Business Development

Shi-ping@paracel.com

   

0

 

(Purchased by Celera June 2000)

 
  1.  

Artemis Pharmaceuticals GmbH

www.artemis-pharmaceuticals.de

Privately held (to be acquired by Exelixis)

Neurather Ring 1

D-51063

Koln

   

Germany

49-0-221-964530

49-0-221-9645321

Peter Stadler, CEO

     

0

 

Acquired by Exelexis Pharmaceuticals Inc.

 
  1.  

Rapigene Inc.

www.rapigene.com

Privately held (subsidiary)

1725 220th Street SE

Suite 200

Bothell

WA

98021

USA

425-398-3100

425-398-3150

Nick McCooke, President and COO

     

1

Owned by Qiagen

   
  1.  

GenoSpectra Inc.

www.genospectra.com

Privately held

6519 Dumbarton Circle

Suite 506

Fremont

CA

94555

 

(510) 818-2600

510.818.2610

Frank Witney, CEO

Anthony C. Chen, President

info@genospectra.com

2000

GENEFNL,

INSTRMT, SUPPLYR

0

   

30jul02

  1.  

PsychoGenics Inc.

www.psychogenics.com

Privately held

4 Skyline Drive

 

Hawthorne

NY

10532

 

(914) 593-0640

(914) 593-0645

Emer Leahy, President and CEO

info@psychogenics.com

   

0

     
  1.  

Bresagen

www.bresagen.com.au

Privately held

PO Box 259

Rundle Mall

Adelaide

 

5000

Australia

61-8-8234-2660

61-8-8234-6268

John Smeaton, Managing Director

Jsmeaton@bresagen.com

   

0

     
  1.  

Exgenix

www.exgenix.com.au

Privately held

576 Swan Street

 

Richmond

Victoria

3121

Australia

61-3-9208-4444

         

0

     
  1.  

Proteome Systems Ltd

www.proteomesystems.com

Privately held

Locked Bag 2073

 

North Ryde, 1670

NSW

2113

Australia

61-2-9889-1830

61-2-9889-1805

Keith L. Williams, CEO

Keith.Williams@ProteomeSystems.com

   

0

 

Proteome Systems is distinct from Proteome Inc., which was acquired by Incyte Genomics in December 2000.

 
  1.  

Devgen NV

www.devgen.com

Privately held

Technologiepark 9

9052 Zwijnaarde

     

Belgium

32-9-264-5402

32-9-264-5418

Theirry Bogaert, CEO and CSO

     

0

     

132.   

Eurogentec SA

www.eurogentec.com

Privately held

Parc scientifique du Sart Tilman

 

Seraing

 

4102

Belgium

32.4.366.61.00

32.4.264.07.88

Joseph Martial, Chairman and Founder

info@eurogentec.com

   

0

     
  1.  

Act Genomics Inc.

www.actgenomics.com

Privately held

6100 Royalmount Avenue

 

Montréal

Québec

 

Canada

 (514) 496-1185

(514) 496-9503

Moussa Hoummady

actgenomics@aol.com

   

0

     
  1.  

Active Pass Pharmaceuticals Inc.

www.activepass.com

Privately held

520 West 6th Avenue

 

Vancouver

BC

 

Canada

(604) 879-2775

(604) 879-2707

Peter Reiner, Presidnet and CEO

info@activepass.com

   

0

     
  1.  

Aegera Therapeutics Inc.

www.aegera.com

Privately held

810 chemin du Golf

Ile des Soeurs

Montreal

Québec

 

Canada

(514) 288-5532

(514) 288-9280

Michael Atkin, CEO

admin@aegera.com

   

0

     
  1.  

BioTools Inc.

www.biotools.com

Privately held

800 Ironwood Professional Center

10050 - 112 Street

Edmonton

Alberta

T5K 2J1

Canada

(780) 423-1133

(780) 423-1333

Gordon Stranks, President & CEO

biotools@biotools.com

   

0

     
  1.  

Cytochoma Inc.

www.cytochroma.com

Privately held

116 Barrie Street

Suite 2424Bioscience Complex Queen's University

Kingston

Ontario

 

Canada

(613) 531-9995

(613) 531-6580

Robert Foldes, President and CEO

robert@cytochroma.com

   

0

     
  1.  

Elitra Canada Ltd.

www.elitra.com

Privately held

225 President Kennedy Ave. W.

Suite 2550

Montreal

Québec

 

Canada

(514) 987-4615

(514) 987-0389

Iraj Beheshti, General Manager

info@elitra.com

   

0

     
  1.  

Ellipsis Biotherapeutics Corp.

 

Privately held

70 Glengowan Road

 

Toronto

Ontario

M4N 1G

Canada

(416) 485-2185

(416) 489-4230

Jacqueline Le Saux, President

     

0

     
  1.  

Galileo Genomics Inc.

www.galileogenomics.com

Privately held

880, McCaffrey

 

St-Laurent

Quebec

H4T 2C7

Canada

514-270-3991

888.224.0388

514-270-4991

John Hooper, President and CEO

info@galileogenomics.com

1999

genepop, genefnl

0

Population genetics of N Quebec Founder Population

 

27aug02

  1.  

Genechem

www.genechem.com

Privately held

1001, de Maisonneuve O.

Suite 920

Montreal

Quebec

H3A 3C8

Canada

514-849-7696

 

Louis Lacasse, President

     

0

     
  1.  

GeneFocus

www.genefocus.com

Privately held

560 Parkside Drive

 

Waterloo

ON

N2L 5Z4

Canada

519-886-9013

519-886-8442

A. E. (Ted) Dixon, President

Aedixon@confocal.com

   

0

 

Subsidiary of Biomedical Photometrics

 
  1.  

Geneka Biotechnology Inc.

www.geneka.com

Privately held

5445 DeLorimier

Suite 401

Montreal

Quebec

H2H 2S5

Canada

888-343-6352

514-528-9233

888-528-9225

514-528-9225

Rino N. Camato, President and CEO

info@geneka.com

   

0

     
  1.  

GenOps Bioinformatics Inc.

www.genops.com

Privately held

4259 Canada Way

Suite 245

Burnaby

BC

V5G 1H1

Canada

(604) 451-2441

(604) 451-2445

Han Yu, Acting CEO and President

info@genops.com

   

0

 

Partially owned by PanGenomics Inc.

 
  1.  

Infection Diagnostic Inc.

www.infectio.com

Privately held

2050 boul. Rene Levesque Ouest

4th floor

Sainte-Foy

Québec

 

Canada

(418) 681-4343

(418) 681-5254

Pierre Coulombe, President & CEO

jacquesmilette@infecto.com

   

2

     
  1.  

Inphogene BioCom Inc.

www.inphogene.com

Privately held

309 - 4475 Wayburne Drive

 

Burnaby

BC

V5G 3L1

Canada

604.453.5900

604.453.5910

Chris Carthy, President

     

0

     

147.   

Integrative Proteomics Inc.

www.integrativeproteomics.com

Privately held

100 University Avenue

Tenth Floor (South Tower)

Toronto

ON

M5J 1V6

Canada

416-645-6600

416-598-1262

John Mendlein, CEO

Info@integrativeproteomics.com

   

0

     

148.   

Kinetek Pharmaceuticals Inc.

www.kinetekpharm.com

Privately held

1200 West 73rd Avenue

Suite 850

Vancouver

BC

V6P 6G5

Canada

(604) 267-7654

(604) 267-7667

André Archimbaud, President & CEO

info@kinetekpharm.com

   

0

     
  1.  

Mirador DNA Design Inc.

www.mirador.ca

Privately held

5252 deMaisonneuve West

Suite 105B

Montréal

Québec

 

Canada

(514) 285-2289

(514) 285-4969

Pierre Sévigny, President & CEO

mirador@protocolscience.com

   

0

     

150.   

Molecular Mining Corp.

www.molecularmining.com

Privately held

128 Ontario Street

 

Hamilton

ON

K7L 2Y4

Canada

613-547-9752

613-547-6835

Evan Steeg, President and CEO

Info@molecularmining.com

   

0

     
  1.  

Newfound Genomics

www.newfound-genomics.com

Privately held

187 LeMarchant Road

 

St. John's

Newfoundland

A1C 2H5

Canada

(709) 753 3900

(709) 753 1927

Proton Rahman, Manging Director & CSO

siobhan.coady@newfound-genomics.com

   

0

     

152.   

PhageTech Inc.

www.phagetech.com

Privately held

P.O. Box 387

Place du Parc

Montreal

Québec

H2W 2N9

Canada

(514) 282-0990

(514) 282-9889

Dalal Manoli, President & CEO

info@phagetech.com

   

0

     
  1.  

Phenogene Therapeutics Inc.

www.phenogene.com

Privately held

416 de Maisonneuve West

Suite 1020

Montreal

Québec

H3A 1L2

Canada

(514) 288-9099

(514) 288-1111

Robert Knapen, CEO

knapenr@phenogene.com

   

0

     

154.   

Pro-DNA Diagnostics Inc.

www.proadn.com

Privately held

5345, boul. de l'Assomption

bur.165

Montréal

Québec

 

Canada

(514) 253-9998

(514) 899-9669

Lambert Busque, Scientific Director

info@proadn.com

   

0

     

155.   

ProMetic Life Sciences Inc.

www.prometic.com

Privately held

6100 Royalmount Avenue

 

Montreal

Quebec

H4P 2R2

Canada

514-496-2115

514-496-2079

Pierre Laurin, President and CEO

info@prometic.com

   

0

     
  1.  

QuantaNova Canada Ltd.

www.bionova.ns.ca/members/quant1.html

Privately held

15 Chipman Drive

PO Box 818

Kentville

Nova Scotia

B4N 4H8

Canada

902-678-5534

902-678-9440

Michael Winther, Presiden

qncan@quantanovacanada.com

   

0

Research arm of Scotia Holdings, UK

   
  1.  

RabbitHutch Biotechnology Inc.

www.rabbithutch.com

Privately held

Box 506

108 Mile Ranch

 

BC

V0K 2ZO

Canada

250-791-1937

250-791-1938

 

Info@rabbithutch.com

   

0

     
  1.  

SeeDNABiotech Inc.

www.seedna.com

Privately held

P.O. Box 21082

 

Windsor

Ontario

 

Canada

(519) 252-8669

(519) 252-2915

Henry Heng, President

fish@seedna.com

   

0

     
  1.  

Solanum Genomics International Inc.

www.solanumgenomics.nb.ca

Privately held

P.O. Box # 636

Station A

Fredericton

NB

 

Canada

(506) 444-2444

(506) 444-5662

Barry Flynn, Director of Research

bflinn@fundy.net

?

agrivet

0

 

Potato genomics

27aug02

  1.  

Xenon Bioresearch Inc.

www.xenonbioresearch.com

Privately held

NRC Innovation Centre

3250 East Mall

Vancouver

BC

V6T 1W5

Canada

604-822-3995

604-822-4366

Frank Holler, President and CEO

     

(0)

     
  1.  

Bios Chile IGSA

www.bioschile.cl

Privately held

Avenida Marathon

1943

Santiago

   

Chile

52-2-2381878

56-2-2394250

Pablo Valenzuela, CEO

Ventas@bioschile.cl

   

0

     
  1.  

Capital BioChip

www.capitalbiochip/eindex.htm

Privately held

Jia 2#

Qinghua West Road

Haidian District

Beijing

100084

China

86-10-62566808

86-10-62566806

Xuenong Zhu, President and CEO

webmaster@capitalbiochip.com

   

0

     
  1.  

E-Life Gene Medicine Co.

www.el-gene.com

Privately held

Room 503

506, Royal Garden Mansion

6 Taiping Men Stree

Nanjing

 

China

86-025-4821980

86-025-4821980-8012

 

e-life@el-gene.com

   

0

     
  1.  

Shaanxi Super Science and Technology Co. Ltd.

 

Privately held

   

Xi'an

   

China

   

Ru Xiaorong

     

0

 

Mircoarray chip for prenatal genetic testing

 
  1.  

Exiqon A/S

www.exiqon.com

Privately held

Bygstubben 9

 

Vedbaek

 

DK-2950

Denmark

45.45.66.08.88

45.45.66.18.88

Mikael Ørum, President and CEO

exiqon@exiqon.com

   

2

     
  1.  

Inoxell AS

www.inoxell.com

Privately held

6, Kogle Alle

DK-2970

Horsholm

   

Denmark

45 45 16 25 25

45 45 16 25 00

Peter Kristensen, CEO

     

0

Website notes 4 patents issued (2 WO, 1 AU, 1 EP) and 7 pending patents (2 US, 2 WO, 1 KR, 1 CA, 1 JP).

Spun out of Pharmexa A/S 30 May 2001.  Pharmexa formerly M&E Biotech. 

 
  1.  

ExonHit Therapeutics SA

www.exonhit.com

Privately held

26 rue Brunel

F-75017

Paris

   

France

33-1-58 05 47 00

33-1-58 05 47 19

Bruno Tocque, CEO

exonhit@exonhit.com

1998

Drugdev, genexpr,

genefnl, phrmgen

1

 

Cancer and neurodegen drug discovery; founded with ANVAR grant

27aug02

  1.  

Gene-IT SA

www.gene-it.com

Privately held

147, Avenue Paul Doumer

 

Rueil

malmaison

92500

France

33.1.41.96.80.30

33.1.41.96.80.31

Jean-Jacques Codani, Chairman and CEO

contact@gene-it.com

   

0

     
  1.  

Genfit SA

www.genfit.com

Privately held

Parc Eurasante

310, avenue Eugene Avinee

59120 Loos

   

France

33-03-28-55-90-60

33-03-28-55-90-61

Jean-Charles Furchart, Chairman

     

0

     

170.   

GenOdyssee SA

www.genodyssee.com

Privately held

Parc d’Affaires Technopolis

3, avenue du Canada

Bat Alpha, PB 810

Courtaboef

France

Les Ulis 91974

France

33-1-69-29-80-55

33-1-69-29-80-79

Jean-Louis Escary, President and CSO;

Didier Lanson, CEO

Escary@genodyssee.com

   

0

 

SNP and other genomics; founded with ANVAR funds

 
  1.  

Genome Express

www.genomex.com

Privately held

11, chemin des Pres

 

Meylan

 

38944

France

33.476.88.53.74

33 (0)4 56 38 11 04

33 (0)4 56 38 11 09

Yves Laurent

y.laurent@genomex.com

   

0

 

For info in US: 1610 NE Eastgate Blvd Suite 880

Pullman, WA 99163 USA

509-332-8080

 
  1.  

GenOway

www.genoway.com

Privately held

46, allee d’Italie

69007

Lyon

   

France

33-146-02-5800

33-146-02-2511

Alexander Fraichard, CEO

     

0

     
  1.  

Molecular Engines Laboratories

www.molecular-engines.com

Privately Held

10, rue Mercoeur

 

Paris

75011

 

France

33-1-55-25-60-63

33-1-55-25-60-73

Claude Hennion, President and CEO

Chennion@molecular-engines.com

2000

 

0

     
  1.  

UroGene SA

www.urogene.com

Privately held

Genopole

4, rue Pierre Fontaine

Evry

 

91000

France

33.1.60.87.89.90

33.1.60.87.89.89

Christian Grenier, CEO

info@urogene.com

c.grenier@urogene.com

   

0

     
  1.  

ValiGen SA.

www.valigen.net

Privately held

Tour Neptune

92086

Paris-La-Defense

   

France

33 1 47 67 66 00

33 1 49 06 07 15

Jean-Louis Pourny, CEO

     

0

     
  1.  

Atugen AG

www.atugen.com

Privately held

Robert-Rossle-Strasse 10

13125

Berlin

   

Germany

USA

49-30-9489-2700

49-30-9489-2701

Rudi Neirinckx, CEO, President and chairman

     

0

     

177.   

Axaron Bioscience AG

www.axaron.com

Privately held

Im Neuenheimer Feld 515

 

Heidelberg

 

69120

Germany

49 (0) 6221 454 702

49 (0) 6221 454 700

Christopher Missling, Exec. VP

susanne.thoet@axaron.com

   

0

 

Mainly owned by BASF and Lynx Therapeutics

 
  1.  

BioCat GmbH

www.biocat.de

Privately held

Im Neuenheimer Feld 581

 

Heidelberg

 

D-69120

Germany

49(0)6221-5858-44

49(0)6221-5858-09

Michael Ehret and Jurgen Huber, General Managers

info@biocat.de

   

0

     
  1.  

Biomax Informatics AG

www.biomax.de

Privately held

Lochhamer Straße 11

 

Martinsried

 

82152

Germany

49-89-89-55-74-0

49 89 89-55-74-25

Klaus Heumann, CEO

Info@biomax.de

   

0

     
  1.  

DeveloGen AG

www.develogen.com

Privately held

Rudolf-Wisselstrasse 28

 

Gottingen

 

D-37079

Germany

49-551-505-58512

49-551-505-58586

Guenther Karmann, CEO

karmann@develogen.com

1997

Genefnl, genetfr

0

Website notes licenses or ownership of 17 patents worldwide, but lists no patents assigned to DeveloGen

Merger of Develogen and HepaVax Oct 2000

27aug02

  1.  

Epidauros Biotechnologie AG

www.epidauros.com

Privately held

Am Neuland 1

D-82347

Bernried

   

Germany

49-8158-9985-0

49-8158-9985-48

Gunther Heinrich, President and CEO

info@epidauros.com

   

0

     
  1.  

Epigenomics GmbH

www.epigenomics.com

Privately held

Kastanienallee 24

D-10435

Berlin

   

Germany

49-30-24-34-5-0

49-30-24-34-5-555

Alexander Olek, President and CEO

Olek@epigenomics.com or danek@epigenomics.com

   

0

     
  1.  

FeBiT GmbH

(Perrarius Biotechnology)

www.febit.com

Privately held

Käfertalerstrasse 190

 

Mannheim

 

D-68167

Germany

49-621-3804-201

49-621-3804-400

Peer F. Staehler, CSO

     

0

     
  1.  

Genomatix

www.genomatix.de

Privately held

 

Karlstrasse 55

München

Bavaria

D-80333

Germany

49-89-54 90 83-90

49-89-54 90 83-92

49-89-54 90 83-99

Thomas Werner, CEO

Werner@gsf.de

   

0

     
  1.  

GenProfile AG

www.genprofile.com

Privately held

Robert-Rossle-Straus

D-13125

Berlin-Buch

   

Germany

49-30-9489-2150

49-30-9489-2151

Margret Hoehe (Max Delbruck Center)

     

0

     
  1.  

GPC AG (Genome Pharmaceuticals)

www.gpc-ag.com

Privately held

Fraunhoferstrasse 20

D-82152

Martinsreid-Munich

   

Germany

49-0-89-85-65-26-00

49-0-89-85-65-26-10

Bernd Seizinger, CEO

     

8

0 for GPC but 8 for Mitotix, acquired in 2000

   
  1.  

Graffinity Pharmaceuticals AG

www.graffinity.com

Privately held

Im Neuenheimer Feld 518-519

 

Heidelberg

 

69120

Germany

49-0-6221.649.3.0

49-0-6221.649.3311

Dirk Vetter, CEO

office@graffinity.com

   

0

     

188.   

Kelman GmbH

www.kelman.de

Privately held

Innovationspark Wuhlheide, Haus 40

Koepenicker Strasse 325

Berlin

 

D-12555

Germany

49-30-6576-3600

49-30-6576-3601

Stephan Heymann, CTO

Info@kelman.de or genenetwork@kelman.de

   

0

     
  1.  

MediGene AG

www.medigene.de

Privately held

Lochhamer Str. 11

D-82152

Planegg-Martinsreid

   

Germany

49-89-89-56-32-0

49-89-89-56-32-20

Peter Heinrich, CEO

     

0

     
  1.  

MediGenomix GmbH

www.medigenomix.de

Privately held

Lochhamer Str.29

D-82152

Planegg/Martinsreid

   

Germany

49-0-89-89-98-92-12

49-0-89-89-98-92-90

Hanns-Georg Klein

     

0

     
  1.  

Micromet AG

www.micromet.de

Privately held

Am Klopferspitz 19

D-82152

Martinsried / Planegg

   

Germany

49 (0)89 895277-0

49 (0)89 895277-22

 

evelyn.wolf@micromet.de

   

0

     

192.   

Morphochem AG

www.morphochem.com or

www.morphochem.de

Privately held

Gmunder str. 37-37a

Suite 116

Muenchen

 

81379

Germany

49-0-89-78005-0

49-0-89-78005-555

Lutz Weber, CEO

Info@morphochem.com

   

0

     
  1.  

MWG Biotech AG

www.mwg-biotech.com

Privately held

Anzingerstrasse 7a

 

Ebersberg

NC

D-85560

Germany

49-0-8092-8289-929

49-0-8092-8289-514

Matthias Schonermark, CEO WMG-Biotech

Russell Golson, Head of Genomic Technology

pr@mwgdna.com

   

0

 

Joint US-German firm (survey sent to German address)

 
  1.  

U3 Pharma AG

www.u3pharma.com

Privately held

Bunsenstr.1

 

Martinsried

 

D-82152

Germany

49 89 8103 90

49 89 8103 9199

Mike Rothe, CSO

Axel Ullrich, Scientific Founder

info@u3pharma.com

   

0

     
  1.  

WITA Proteomics AG

www.wita-proteomics.com

Privately held

Warthestrasse 21

 

Teltow

 

D-14513

Germany

49 (0) 3328 3949 0

49 (0) 3328 3949 49

Andreas Kopke, CEO

 info@wita-proteomics.com

   

0

     
  1.  

Xantos biomedicine AG

www.xantos-bio.de

Privately held

Fraunhoferstrasse, 22

   

Martinsreid

82152

Germany

49.89.899.59.400

49.89.899.59.420

Peter Buckel, CEO

info@xantos.de

1999

 

0

     
  1.  

ComGenex

www.comgenex.com

Privately held

1027 Budapest Bem rkp. 33-34

1388

Budapest

 

62

Hungary

36-1-214-2306

36-1-214-2310

Ferenc Darvas, President and CEO

info@comgenex.hu

   

0

     
  1.  

Iceland Genomics Corp.

www.uvs.is and www.icelandgenomics.com although this second site not operating 5 Apr 01

Privately held

Urour Veroandi Skuld

Lynghalsi 10

 

Reykjavik

 

10

Iceland

354-525-3600

354-525-3608

Berhard O. Palsson, CEO

Uvs@uvs.is

   

0

     
  1.  

Questar BioInformatics Ltd.

www.questarbio.com

Privately held

(equity by Glan Pharma and other investors)

6-3-862 Ameerpet

 

Hyderabad

 

500 016

India

91-40-340 2415/ 340 2157

91-40-340 2229

C. S. N. Murthy, CEO

info@questarbio.com

2000

 

0

 

Bioinformatics firm, incl. functional genomics

 
  1.  

Strand Genomics

www.strandgenomics.com

Privately held

146, 5th Cross

RMV Extension

Bangalore

 

560 080

India

91-80-3467567
+91-80-3468184

91-80-3467568

Srinivasan Seshadri, CEO

info@strandgenomics.com

   

0

     
  1.  

EiRx Therapeutics Ltd.

www.eirxtherapeutics.com

Privately held

2800 Airport Business Park

Kinsale Road

Cork

   

Ireland

353-021-4320847

353-021-4320848

Peter Daly, CEO

Pdaly@eirxtherapeutics.com

   

0

     
  1.  

HiberGen

www.hibergen.com

Privately held

IDA Business Park

Bray

County Wicklow

   

Ireland

353-1-276-9870

353-1-808-2438 CEO

353-1-276-9888

Maurice N. Treacy, CEO

Mtreacy@hibergen.com

   

0

     
  1.  

idGENE Pharmaceuticals Ltd.

www.idgene.com

Privately held

Beit Ofer, 5 Haftzrfi Street

PO Box 34478

Jerusalem

 

91344

Israel

972-2-659-5600

972-2-659-5601

Ariel Darvasi, President and CEO

Contact@idgene.com

   

0

     
  1.  

Dragon Genomics

www.takara.co.jp

Privately held

Takara Shuzo Co., Ltd.

Biomedical Group

Seta 3-4-1, Otsu

Shiga

520-2193

Japan

81-77-543-7247

81-77-543-9254

Makoto Moriguchi, President and CEO

Bio-sm@takara.co.jp

   

0

Parent company Takara Shuzo has 41 DPP patents

   

205.   

HuBit Genomix

www.hubitgenomix.com/eng

Privately held

Joware Hanzoumon Building 2F

2-19 Hayabusa-cho, Chiyoda-ku

Tokyo

 

102-0092

Japan

81-3-5212-3360

81-3-52123384

Hiromichi Kimura, CEO

     

0

Initially Medical Genome Systems (founded April 2000)

   
  1.  

Medibic

www.medibic.com

Privately held

         

Japan

81-3-3280-3987

81-3-3280-2255

Yasuhiro Hashimoto, CEO

Info@medibic.com

   

0

     
  1.  

Xanagen Inc.

www.xanagen.com

Privately held

KSP D-1037

3-2-1 Sakado

Takatsu-ku

Kawasaki

213-0012

Japan

81-44-829-3031

81-44-813-1651

Yutaka Ado, President

     

0

 

Jointly owned by Kyowa Hakko Kogyo Co., Ltd. and Mitsui Knowledge Industry Co., Ltd.

 
  1.  

Bioneer Inc.

www.bioneer.com

Privately held

High Tech Park

Chuckbook-Ri

Mwee-Myon

Cheongwon-Gun

Chungchongbuk-Go

Korea

   

Han-Oh Park, President and CEO

info@bioneer.com

   

3

     
  1.  

CrystalGenomics Inc.

crystalgenomics.com

Privately held

Daeduck BioCommunity

461-6 Jeonmin-dong

Yusung-gu

Taejon

305-390

Korea

82.42.866-9300

82.42.866-9301

Joong Myung Cho, President and CEO

Info@crystalgenomics.com

   

0

     

210.   

Genocheck

www.genocheck.com

Privately Held

     

Ansan

 

Korea

           

0

     
  1.  

Genomine

www.genomine.com

Privately held

Environmental Eng. Bldg

University of Science and Technology Pohang

Kyungbuk

Pohang 226

790-784

Korea

   

Hong-Gil Nam

bjkang@postech.ac.kr

   

0

     
  1.  

MyDNA

www.m;ydna.co.kr

Privately held

401, Inbong Building

Yeoksam-dong

Kangnam-gu

Seoul

640-21

Korea

82-2-556-1559

82-2-555-2598

Gary Song, President and CEO

dabb@mydna.co.kr

   

0

     
  1.  

SuperBioChips Laboratories Inc.

www.tissue-array.com

Privately held

824-11 Yuksam-dong

Rm 1403-2

Seoul

 

135-934

Korea

82-2-3676-8270

82-2-3676-8269

       

0

     
  1.  

Lynk Biotechnologies Inc.

www.lynk-biotech.com

Privately held

41 Science Park Road

The Gemini Building #01-21/22 Singapore Science Park II

Singapore

 

117610

Singapore

65 - 872-7388

65 - 775-9081

Lee Chee Wee, Acting CEO

info@lynk-biotech.com

   

0

     
  1.  

ToolGen Inc.

www.toolgen.co.kr

Privately held

461-6 Jeonmin-dong

Yuseong-gu

Taejon

 

305-390

South Korea

82-42-863-8166~8

82-42-863-3840

Jin-Soo Kim, President and CEO

toolgen@toolgen.com

   

0

     
  1.  

Oryzon Genomics

www.oryzon.com

Privately held

Institute of Molecular Biology

 

Barcelona

   

Spain

   

Carlos Buesa, CEO

 

2000

GENEFNL, GENEXPR

0

   

27jul02

  1.  

Global Genomics AB

www.globalgenomics.com

Privately held

Tomtebodavagen 21B

 

Stockholm

 

S-171 77

Sweden

46.8.50.88.47.10

46.8.30.17.50

Ulf Boberg, CEO

ulf@globalgenomics.com

   

0

     
  1.  

UmanGenomics AB

www.umangenomics.com

Privately held

Umestan

SE-903

Umea

 

47

Sweden

46-90-71-80-90

46-90-71-80-95

Sune Rosell, President

Info@umangenomics.com

   

0

     
  1.  

Visual Bioinformatics

www.visual-bioinformatics.com

Privately held

Royal Institute of Technology

Fiskartorpsvägen 15 A

Stockholm

   

Sweden

46-8-676 65 60

46-8-676 65 69

Eugen Steiner, CEO

contact@visualbioinformatics.com

   

0

     
  1.  

Gene Data AG

www.genedata.com

Privately held

Maulbeerstr. 46

 

Basel

 

CH-4058

Switzerland

41 61 697 6099

41 61 697 7244

Othmar Pfannes, CEO

     

0

     
  1.  

Geneva Bioinformatics

www.genebio.com

Privately held

25 avenue de Champel

1206

Geneva

   

Switzerland

41 22 702.99.00

41 22 702.99.99

Jenny Fichmann, COO

     

0

     
  1.  

DigiGenomics Co. Ltd.

www.digigenomics.com

Privately held

8F 196 Jou-tzu Street

 

Taipei

 

114

Taiwan

886.2.265.98856

886.2.265.98857

 

info@digigenomics.com

2000

INFRMTX, SUPPLYR, GENEXPR, PHRMGEN

0

US Pat pending, EU pat Pending

 

1aug02

  1.  

Vita Genomics Inc.

www.vitagenomics.com

Privately held

5 FL

No. 2, Sec. 2 S. Road

Hsin-Sheng

Taipei

 

Taiwan

886-2-8976-9123

886-2-8976-9523

Ellson Chen, President and CEO

     

0

     
  1.  

Galapagos Genomics BV

www.galapagosgenomics.com

Privately held

BioScience Park Leiden

Zernikedreef 6

2333 CL

Leiden

 

The Netherlands

31-71-524-87-03

31-71-524-87-04

Onno van de Stolpe, Director

     

0

 

Joint Belgian-Dutch firm (survey sent to Belgian address)

 
  1.  

Glaucus Proteomics BV

www.glaucusprot.nl

Privately held

Regulierenring 16

Bunnik

Utrecht

 

3981 LB

The Netherlands

31-30-243-3834

31-30-243-5764

Ian Humphery-Smith, COO

ihs@glacusprot.nl

   

0

     
  1.  

Aneda Ltd.

www.anedabio.com

Privately held

The Logan Building

Roslin Biocentre

Roslin

Midlothian

EH25 9PS

UK

44.131.527.4528

   

enquiries@anedabio.com

   

0

     

227.   

Confirmant Ltd.

www.confirmant.com

Privately held

Unit 66

The Business Development Centre

Milton Park, Abingdon

Oxon

OX14 4RX

UK

44.1235..208111

44.1235..208020

Jonathan Sheldon, Chief Technology Officer

enquiries@confirmant.com

   

0

     
  1.  

DxS Ltd.

www.dxsgenotyping.com

Privately held

Manchester Incubator Building

48 Grafton Street

 

Manchester

M13 9XX

UK

44.161.606.7201

44.161.606.7313

Steve Little, CEO

info@dxsgenotyping.com

Stephen.Little@dxsgenotyping.com

   

0

     
  1.  

Inpharmatica Ltd.

Www.inpharmatica.com

Privately held

60 Charlotte Street

 

London

 

W1P 2AX

UK

44-0-207-631-4644

44-0-207-631-4844

Ken Powell, CEO

K.powell@inpharmatica.com

   

0

     
  1.  

LGC Ltd.

www.lgc.co.uk

Privately held

Queens Road

 

Teddington

Middlesex

TW11 OLY

UK

44.20.8943.7000

44.20.8943.2767

Richard Worswick, Chief Executive

info@lgc.co.uk

1996

GENEXPR, STANDRD

0

Spinoff from 150-year-old Licensed Govt Chemist

DNA Database Laboratory started 1998; Lab-on-Chip 2001

31jul02

  1.  

Microscience Ltd.

www.microscience.com

Privately held

Commonwealth Building

ICSM Hammersmith Campus

Du Cane Road

London

W12 0NN

UK

44-0-20-8383-3301

44-0-20-8383-2071

Rod Richards, CEO

r.richards@microscience.com

   

0

     
  1.  

Oxagen Ltd.

www.oxagen.co.uk

Privately held

91 Milton Park

 

Abingdon

Oxon

OX14 4RY

UK

44-0-1235-443300

44-0-1235-443301

Christine Soden, CFO

c.soden@oxagen.co.uk

   

0

     
  1.  

Oxford Gene Technology

www.ogt.co.uk

Privately held

BioBusiness Park

Littlemore Park

Oxford

 

OX4 4SS

UK

44.1865.405.100

44.1865.405.120

Andrew Millar, Chief of Operations

info@ogt.co.uk

   

5

Licensing Southern patents and developing microarray technologies

Founded by Edwin Southern; co-owned with Oxford Univ

 
  1.  

Solexa Ltd.

www.solexa.co.uk

Privately held

Chesterford Research Park

Little Chesterford, Nr. Saffron Walden

Essex

 

CB10 1XL

UK

44-1799-532-300

44-1799-532-301

Nick McCooke, CEO

info@solexa.com

1998

DNASEQN, GENEXPR, INSTRMT

0

 

Univ Camb spinoff

27aug02

  1.  

Synomics

www.synomics.com

Privately held

Compass House

Vision Park, Histon

Cambridge

 

CB4 9AD

UK

44-1223-257-788

44-1226-257-888

Paula Zanella, Chairman

Pzanella@synomics.com

   

0

 

Acquisition by Accelrys announced 21 June 2001 (Accelrys a subsidiary of Pharmacopeia, Princeton, NJ)

 
  1.  

20/20 GeneSystems Inc.

www.2020gene.com

Privately held

9700 Great Seneca Highway

 

Rockville

MD

20850

USA

866.572.2020

240.453.6339

240.453.6208

Jonathan Cohen, CEO

info@2020gene.com

2000

GENEXPR, INFRMTX

0

   

1aug02

  1.  

3rd Millennium Inc.

www.3rdmill.com

Privately held

125 Cambridge Park Drive

 

Cambridge

MA

02140

USA

617-441-3030

888-373-6455

 

Richard Dweck, CEO

stepone@3rdmill.com

   

0

     
  1.  

Acadia Pharmaceuticals, Inc.

www.acadia-pharm.com

Privately held

3911 Sorrento Valley Blvd.

 

San Diego

CA

92121

USA

619-558-2871

619-558-2872

Mark Brann, President and CSO

     

2

 

IPO scheduled for Aug-Sept 2001 withdrawn Sept 2001

 
  1.  

Adeptient

www.adeptient.com

Privately held

316 Quinnhill Avenue

 

Los Altos

CA

94024

USA

650-947-9487

 

Gokhan Percin, President and CEO

Percin@adeptient.com

Or info@adeptient.com

   

0

     
  1.  

Agencourt Bioscience Corp.

www.agencourt.com

Privately held

100 Cummings Center

Suite 107G

Beverly

MA

01915

USA

800-361-7780

978.867.2600

978.867.2601

R. Brian McKernan, President and CEO

info@agencourt.com

   

0

     
  1.  

Agilix

 

Privately held

P.O. Box  8175

 

New Haven

CT

 

USA

(203) 772-4367

 

Martin J. Mattessich, President and CEO

     

0

 

Yale spinoff; transcriptome analysis.

 
  1.  

AGY Therapeutics

www.agyinc.com

Privately held

290 Utah Avenue

 

South San Francisco

CA

94080

USA

650-615-4530

650-615-4544

Karoly Nikolich, CEO

c@agyinc.com

   

0

     
  1.  

Alanex (owned by Agouron)

www.agouron.com

Privately held

Corporate Headquarters

10350 North Torrey Pines Rd

La Jolla

CA

92037-1020

USA

858-455-3200

858-455-3287

Alex Polinsky, Head of Alanex Research Div.

     

0

     
  1.  

Allelix (NPS Pharmaceuticals, Inc.)

www.npsp.com

Privately held

420 Chipeta Way

 

Salt Lake City

UT

84108

USA

801-583-4939

 

Hunter Johnson, CEO and President

     

22

     
  1.  

Alpha Gene Inc

www.alphagene.com

Privately held

260 W. Cummings Park

 

Woburn

MA

01801

USA

781-933-4446

781-933-5424

Donald J. McCarren, President and CEO

Info@alphagene.com

   

1

     

246.   

Alpha Innotech Inc.

www.alphainnotech.com

Privately held

14743 Catalina St.

 

San Leandro

CA

94577

USA

510-483-9620

510-483-3227

Haseeb Chaudhry, CEO

info@aicemail.com

1992

 

0

.

array and genomics reagents supplier

 

247.   

Amphora Discovery Cop.

www.amphoracorp.com

Privately held

800-4 Capitola Drive

 

Durham

NC

27713

USA

   

Marty Haslager, CEO

corpinfo@amphoracorp.com

2001

 

0

 

Spun out of Caliper Tech

 

248.   

Anadys Pharmaceuticals Inc.

www.anadyspharma.com

Privately held

9050 Camino Santa Fe

 

San Diego

CA

92121

USA

858-530-3603

858-527-1540

Kleanthis G. Xanthopoulos, President and CEO

Dnelson@anadyspharma.com

   

1

One patent from Scriptgen.

Merger of Scriptgen and Askelpios. 

 
  1.  

AnVil Informatics Inc.

www.anvilinfo.com

Privately held

600 Suffolk Street

5th Floor North

Lowell

MA

01854-3629

USA

(978) 934-8821

(978) 937-1850

Howard Berke, CEO

Info@anvilinformatics.com

   

0

     
  1.  

Aptagen

www.aptagen.com

Privately held

520 Huntmar Park Drive

 

Herndon

VA

20170

USA

888-Aptagen;

703-793-8000

703-793-8037

Colin Higbie, President and CEO

Info@aptagen.com

   

0

     
  1.  

Aptus Genomics Inc.

www.aptusgenomics.com

Privately held

Maryland Technology Development Center

9700 Great Seneca Highway

Rockville

MD

20850

USA

240-453-8494

240-453-9409

Kevin Chance, President and CEO

Info@aptusgenomics.com

   

0

     
  1.  

Ardais Corp.

www.ardais.com

Privately held

1 Ledgemont Center

128 Spring Street

Lexington

MA

02421

USA

781.274.6420

781.274.6421

Eric B. Gordon, President and CEO

info@ardais.com

eric_Gordon@ardais.com

   

0

 

clinical genomics firm

 
  1.  

Athersys Inc.

www.athersys.com

Privately held

3201 Carnegie Avenue

 

Cleveland

OH

44115-2634

USA

216-431-9900

216-361-9495

Gil Van Bokkelen, President and CEO

     

1

1st patent April 2002.

IPO registered and withdrawn, Spring 2001

 
  1.  

Avalon Pharmaceuticals Inc.

www.avalonrx.com

Privately held

19 Firstfield Road

 

Gaithersburg

MD

20878

USA

301-556-1000

301-556-1100

Kenneth C. Carter, President and CEO

info@avalonrx.com

1999

drugdev

0

 

Cancer drug devel; moving to Germantown late 2002

27aug02

255.   

Aviva Biosciences Corp.

www.avivabio.com

Privately held

11568-9 Sorrento Valley Road

 

San Diego

CA

92121

USA

858-259-8288

858-259-8685

Julian Yuan, President and CEO

Info@avivabio.com

   

0

     

256.   

Beyond Genomics Inc.

www.beyondgenomics.com

Privately held

150 Cambridge Park Drive

10th Floor

Cambridge

MA

02140

USA

617-218-1694

617-497-2244

N. Stephen Ober, President

Steveo@beyondgenomics.com

   

0

     
  1.  

BioArray Solutions LLC

www.bioarrays.com

Privately held

120 Centennial Ave

 

Piscataway

NJ

08854

USA

   

Michael Seul, Founder

Mseul@bioarrays.com

   

0

Website lists 3 PCT patents pending and excl license to one US patent

   
  1.  

BioDiscovery Inc.

www.biodiscovery.com

Privately held

11150 West Olympic Blvd

Suite 1170

Los Angeles

CA

90064

USA

(310) 966-9366

(310) 966-9346

Soheil Shams, President

info@biodiscovery.com

   

0

     
  1.  

Biognosis Inc.

www.biognosis.com

Privately held

209 Perry Parkway

 

Gaithersburg

MD

20877

USA

301-921-6001

301-921-6011

Andrew Pergen, Vice President, Biognosis US

Abergen@biognosis.com or info@biognosis.com

   

0

     
  1.  

Bionomix Inc.

www.bionomix.com

Privately held

1376 E. Walnut Street

 

Pasadena

CA

91106

USA

   

Derek Debe, CEO

Damin7@kornet.net

   

0

 

Linked to Caltech

 
  1.  

Biosearch Technologies Inc.

www.biosearchtech.com

Privately held

81 Digital Drive

 

Novato

CA

94949-5750

USA

415-883-8400 or 1-800-436-6631

 

Ron Cook, President and CEO

Info@biosearchtech.com

   

0

     
  1.  

BioSeek Inc.

www.bioseekinc.com

Privately held

863-C Mitten Road

 

Burlingame

CA

94010

USA

 

650-552-0725

Peter D. Staple, CEO

info@bioseekinc.com

   

0

     
  1.  

BIOwulf Genomics Inc

www.biowulf.com

(not operating Mar 16,2002)

Privately held

   

Savannah

GA

 

USA

912-691-1441

912-691-2757

Peter Farley, President and CEO

     

0

 

Distinct from BeoWulf Genomics, a nonprofit initiative of the Wellcome Trust for micribial pathogen sequencing

 
  1.  

Blizzard Genomics

www.blizzardgenomics.com

Privately held

2550 University Avenue West

 

Saint Paul

MN

55114

USA

651-646-0164

 

James V. Adam, CEO

info@blizzardgenomics.com

 

INSTRMT, GENEXPR, SUPPLYR

0

   

27jul02

  1.  

Blue Heron

www.blueheronbio.com

Privately held

22310 20th Avenue SE

Suite 100

Bothell

WA

98021

USA

425-368-5000

425-368-4050

Peter R. Nicholson, President and CEO

Info@blueheronbio.com

   

0

     
  1.  

Capital Genomix Inc.

www.capitalgenomix.com

Privately held

2 Cessna Court

 

Gaithersburg

MD

20879-4174

USA

240-401-2801

240-401-7496

301-948-7755

William Hearl, President and CEO

Captlgnomx@aol.com or bhearl@capitalgenomix.com

   

0

     
  1.  

Cartesian Technologies

www.cartesiantech.com/microarray_products.htm

Privately held

17851 Sky Park Circle

Suite C

Irvine

CA

92614

USA

949-440-3680

949-622-0255

Tom Tisone, President

     

0

     
  1.  

Celadon Laboratories Inc.

www.celadonlabs.com

Privately held

387 Technology Drive

 

College Park

MD

20741-3371

USA

301-405-7591

301-314-9592

Larry Kessner, President and CEO

Peterson@celadonlabs.com

   

0

     
  1.  

Cellomics Inc.

www.cellomics.com

Privately held

635 William Pitt Way

 

Pittsburgh

PA

15238

USA

512-826-3600

512-826-3850

D. Lansing Taylor, President and CEO

     

1

 

IPO registered and withdrawn Spring 2001

 
  1.  

Cellular Genomics Inc.

www.cellulargenomics.com

Privately held

25 Science Park

 

New Haven

CT

06511

USA

203-776-0829

203-776-0852

Louis A. Matis, President and CEO

     

0

     
  1.  

CeMines Inc.

www.cemines.com

Privately held

3082 Evergreen Parkway

Suite H

Evergreen

CO

80439

USA

866-236-4637

303-679-3160

 

Support@cemines.com

   

0

     

272.   

Cetek Corp.

www.cetek.com

Privately held

260 Cedar Hill Street

 

Marlborough

MA

01752

USA

508-229-8900

508-229-3344

James L. Waters, President and CEO

j.little@cetek.com

   

0

     

273.   

Chimerx Inc.

www.chimerx.com

Privately held

6143 North 60th Street

 

Milwaukee

WI

53218

USA

414-535-9506 or 800-626-7833

414-535-9508

 

Chimerx@chimerx.com

   

0

 

Reagent firm

 
  1.  

Clinical MicroSensors Inc.

www.microsensor.com

Privately held

126 West Del Mar Boulevard

 

Pasadena

CA

91105

USA

(626) 584-5900

(626) 584-0909

Jon Faiz Kayyem, President and CEO

cms@microsensor.com

   

0

Website lists 12 licensed or assigned patents Nov 2000

   
  1.  

Clontech

www.clontech.com

Privately held

1020 East Meadow Circle

 

Palo Alto

CA

94303

USA

650-424-8222, 800-662-2566

650-424-1352, 800-424-1350

Kenneth Fong, CEO

     

8

     
  1.  

Cogent Neuroscience Inc.

www.cogentneuro.com

Privately held

710 West Main Street

Suite 100

Durham

NC

27701

USA

   

Max Wallace, CEO

     

0

     
  1.  

Commonwealth Biotechnologies Inc.

www.cbi-biotech.com

Privately held

601 Biotech Drive

 

Richmond

VA

23235

USA

800-735-922

804-648-2641

Robert B. Harris, President

info@cbi-biotech.com

   

1

     

278.   

Corimba Inc.

 

Privately held

2161 Shattuck Avenue

Suite 203

Berkeley

CA

94704

USA

510-548-4574

510-548-4594

       

0

     

279.   

Correlogic Systems Inc.

www.correlogic.com

Privately held

6701 Democracy Boulevard.

Suite 300

Bethesda

MD

20817

USA

301-214-4030

301-983-2966

Peter J. Levine, President and CEO

info@correlogic.com

   

0

     
  1.  

Cytopeia Inc.

www.cytopeia.com

Privately held

P.O. Box 85722

 

Seattle

WA

98145-1722

USA

(206) 732-1410

(206) 732-1415

Ger van den Engh, founder

mail@cytopeia.com

   

0

     
  1.  

DiaDexus, LLC

www.diadexus.com

Privately held

(IPO registration filed 11/00)

3303 Octavius Drive

 

Santa Clara

CA

95054

USA

408-496-6600

408-496-5777

Patrick Plewman, CEO

Ir@diadexus.com

   

0

Has exclusive licenses to several patents, noted on website

IPO registration (intent) filed 11/00;

 
  1.  

DiAthegen LLC

www.diathegen.com

Privately held

4 Orchard Lane

 

Athens

OH

45701-1343

USA

740-592-5221

 

John Kopchick, Founder and CSO

kopchick@ohiou.edu

2001

 

0

Website alludes to 8 patents and 6 pending (presumably to Ohio U, licensed to DiAthegen).

Ohio U affil.

 
  1.  

Digital Gene Technologies Inc.

www.dgt.com

Privately held

11149 Torrey Pines Road

 

La Jolla

CA

92037

USA

858-552-1400

858-552-8625

Richard Sutcliffe, President and CEO

Info@dgt.com

bob@dgt.com

   

0

     

284.   

DirectGene Inc.

www.directgene.com

Privately held

2661 Riva Road

Building 500, Suite 520

Annapolis

MD

21401

USA

410-571-7700

410-571-7715

Timothy J. Williamson, President and CEO

info@directgene.com

1999

 

0

 

Cancer Rx

 

285.   

DiscoveRx Corp.

www.discoverx.com

Privately held

42501 Albrae Street

 

Fremont

CA

94538

USA

866-448-4864

510-979-1415

510-979-1650

Pyare Khanna, President and CEO

info@discoverx.com

   

0

     

286.   

Discovery BioSciences

www.discoverybio.com

Privately held

655 NE Northlake Way

 

Seattle

WA

98105

USA

206-675-9220

206-675-1125

David T. Kingsbury, CEO and Tim Hunkapiller, President

Info@discoverybio.com

   

0

 

Also in Foster City, CA

 

287.   

Display Systems Biotech

www.displaysystems.com

Privately held

1260 Liberty Way

Suite B

Vista

CA

92083

USA

Denmark

760-599-0598

45-70-22-22-02

760-599-9930

45-70-23-23-04

 

Tgj@displaysystems.com

   

0

 

Also Denmark:

Vestre Teglgade 8

DK-2450 Copenhagen SV

 
  1.  

DNA Dynamics

www.dnadynamics.com

Privately held

3398 Carmel Mountain Road

Suite 100

San Diego

CA

92121

USA

877.362.2633

858-523-5000

858-523-5001

Tina S. Nova, CEO

 

2000

 

0

     
  1.  

DNA Sciences Inc.

www.dna.com

Privately held

6540 Kaiser Drive

 

Fremont

CA

94555

USA

510-494-4000

510-494-4010

Steve Lehrer, CEO

Info@kivagen.com

   

0

Also checked Kiva

Formerly Kiva Genetics www.kivagen.com

 
  1.  

DNAmicroarray.com

www.dnamicroarray.com

Privately held

         

USA

           

0

 

No address or corp info available online

 
  1.  

DNAStar Inc.

www.dnastar.com

Privately held

1228 S. Park St.

 

Madison

WI

53715

USA

(608) 258-7420

(608) 258-7439

Frederick Blattner, Founder

info@dnastar.com

1982

infrmtx

1

   

27aug02

  1.  

Egea Genomics Inc.

www.egeabiosciences.com

Privately held

4178 Sorrento Valley Boulevard

Suite F

San Diego

CA

92121

USA

858-554-1805

858-554-1806

Glen A. Evans, President and CEO

     

0

     
  1.  

EngeneOS

www.engeneos.com

Privately held

150 CambridgePark Drive

10th floor

Cambridge

MA

02140

USA

617-497-2233

617-497-2244

Frank Lee, President and CEO

Mail@engeneos.com

   

0

1 patent for Engene Biotechnologies, a different company of Rancho Santa Fe, Calif.

   
  1.  

Entelos Inc.

www.entelos.com

Privately held

4040 Campbell Ave

Suite 200

Menlo Park

CA

94025

USA

650-330-5200

650-330-5201

James Karis, President and CEO

Company_info@entelos.com

1996

Infrmtx

0

 

Modeling of disease

27aug02

  1.  

Entigen Corp.

www.entigen.com

Privately held

930 Hamlin Court

 

Sunnyvale

CA

94089

USA

408-542-5500

408-734-3770

Denise Gilbert, CEO

Support@entigen.com

   

0

 

Formed by merger of eBioinformatics and Empatheon

 
  1.  

Entropia Inc.

www.entropia.com

Privately held

10145 Pacific Heights Blvd.

Suite 800

San Diego

CA

92121

USA

(858) 623-2840

(858) 623-2847

Robert North, CEO

msierras@entropia.com

   

0

     
  1.  

Eos Biotechnology Inc.

www.eosbiotech.com

Privately held

225A Gateway Blvd.

 

South San Francisco

CA

94080

USA

650-246-2300

650-583-3881

David Martin, CEO and President

bcalvin@eosbiotech.com

   

0

 

Acquisition by Pharmacopeia announced Aug 2001. Merger terminated Jan 2002.

 
  1.  

Epicentre Technologies Corp.

www.epicentre.com

Privately held

1402 Emil Street

 

Madison

WI

53713

USA

608-258-8474

888-284-8474

608-258-3088

Jerome J. Jendrisak

     

4

     

299.   

EraGen Biosciences

www.eragen.com

Privately held

918 Deming Way

 

Madison

WI

53717

USA

608-662-9000

608-662-9003

Irene Hrusovsky, President and CEO

info_general@eragen.com

1999 or before

PHRMGEN,GENEFNL, CLINSVC, INFRMTX

7

0 Patents assigned to EraGen in DPD, but 7 liasting Steven Benner as inventor or co-inventor (one assigned to Hoechst); website lists 8 patents issued and many continuations pending, all to company co-founder Benner, Zurich CH and Gainesville FL; presumably licensed to EraGen

Bayh-Dole rights not noted in patents; NIGMS and NASA grants acknowledged in publications

26aug02

300.   

Evolutionary Genomics

www.evolgen.com

Privately held

6840 N. Broadway

Suite A

Denver

CO

80221

USA

303.429-5079

303-429-8608

Ginny Orndorff, President and CEO

info@evolgen.com

   

1

     
  1.  

Fairfield Enterprises Inc.

 

Privately held

PO Box 1366

 

Los Alamos

NM

87544

USA

505-662-3115

505-662-3123

Eric Fairfield, President

Fairfiel@trail.com

eric@fairfieldenterprises.biz

   

0

 

Developing “alternatives to luminescence detection” for arrays, etc.

 
  1.  

First Genetic Trust Inc.

www.firstgenetic.net

Privately held

8770 West Bryn Mawr Avenue

Suite 1300

Chicago

IL

60631

USA

773-867-2990

773-867-2991

Arthur L. Holden, CEO

Aholden@firstgenetic.net

 

LEGLSVC

NA

 

Focused on privacy of genetic info as trusted intermediary

 
  1.  

Framingham Genomic Medicine

www.fgmed.com (not yet functioning)

Privately held

(dissolved)

715 Albany Street

Suite T-120 West

Boston

MA

02118

USA

617-414-4556

617-414-6141

Fred Ledley, CSO

 

2000

 

0

 

Formed June 2000, 20% stock held by Boston Univ.; dissolution announced January 2001

 
  1.  

Gamera BioScience

www.gamerabioscience.com

Privately held

200 Boston Avenue

Suite 1850

Medford

MA

02155

USA

 

781-306-0837

John Campbell, Executive Director

     

2

     
  1.  

GenBasix Inc.

www.genbasix.com

Privately held

1500 E. Duarte Road

 

Duarte

CA

91010

USA

626-301-8832

626-301-8912

William L. Hughes, CEO

     

0

     
  1.  

Gene Tec

www.ncbiotech.org/genetec.htm

Privately held

205 Winterberry Ridge Drive

 

Durham

NC

27713

USA

919-493-2022

 

Marilyn Stapleton, President

mstapleton@ntrnet.net

   

6

     

307.   

GeneFormatics Inc

www.geneformatics.com

Privately held

5830 Oberlin Drive

Suite 200

San Diego

CA

92121-3754

USA

858-450-3331

858-450-1138

John Chiplin, President and CEO

Jacque@geneformatics.com Jacquelyn Fetrow, scientific founder

1998

Infrmtx, genefnl, drugdev, dnaseqn

0

2001 merged with Structure Function Genomics LLC; website has “IP” page that notes trade secrets and “patent strategies” but lists no patents

Started as bioinformatics, moved to protein structure, now pursuing drug development

27aug02

  1.  

GeneGo LLC

www.genego.com

Privately held

21 Chrismar Road

 

Portage

IN

46368

USA

219-763-9756

925-362-9698

Tatiana Nikolskaya, President and CEO

Tatiana@genego.com

   

0

     
  1.  

GeneMachines Inc.

www.genemachines.com

Privately held

935 Washington Street

 

San Carlos

CA

94070

USA

650-508-1634

650-508-1644

Scott Hunicke-Smith, CEO

     

0

     
  1.  

GeneSeek Inc.

www.geneseek.com

Privately held

4701 Innovation Drive

 

Lincoln

NE

68521

USA

402-472-5133

402-472-4203

Abe Oommen, President and CEO

Aoommen@geneseek.com or help@geneseek.com

   

0

 

Genotyping and sequencing; farm animal genotyping and diagnosis

 
  1.  

Genetica Inc.

www.geneticainc.com

Privately held

PO Box 99

 

Cold Spring Harbor

NY

11724

USA

516-367-8847

516-367-8874

David Beach, President

     

0

(3 Patents for a Genetica of Joinville Le Pont, France, but not same company?)

   

312.   

GeneticXchange

www.geneticxchange.com

Privately held

713 Santa Cruz Avenue

 

Menlo Park

CA

94025-4519

USA

650-321-9573

650-321-9523

Brian P. Donnelly, President and CEO

Info@geneticxchange.com

1998

INFRMTX

0

 

Collaboration with Stanford University and PharmacoGenetics Knowledge Base www.pharmgkb.org

30jul02

  1.  

GeneTrace Systems Inc.

www.genetrace.com

Privately held

1401 Harbor Bay Parkway

 

Alameda

CA

94502

USA

510-748-6000

510-748-6001

George LaMotte, CEO

Info@genemachines.com

   

1

     
  1.  

Geneva Proteomics

www.geneprot.com

Privately held

1840 Oak Avenue

 

Evanston

IL

60202

USA

847-344-2887

847-328-8432

Cedric Loiret-Bernal, CEO

Cedric.loiret-bernal@geneprot.com

   

0

     

315.   

Genicon Sciences Corp.

www.geniconsciences.com

Privately held

11585 Sorrento Valley Road

 

San Diego

CA

92121

USA

(858) 793-0276

(858) 793-6791

Patrick J. Mallon, President and CEO

     

0

     
  1.  

Genomatica Inc.

www.genomatica.com

Privately held

5405 Morehouse Drive

Suite 210

San Diego

CA

92121

USA

858.824.1771

858.824.1772

Bernhard Palsson, Chairman and Acting CEO

info@genomatica.com

   

0

     
  1.  

Genome Dynamics Inc.

 

Privately held

17800 Mill Creek Drive

 

Derwood

MD

20855

USA

20879-5536

301-926-0921

       

0

     
  1.  

Genome International Corp.

www.msn.fullfield.com/~sena

Privately held

383 D’Onofrio Drive

Suite 3

Madison

WI

53719

USA

608-833-5855

 

Periannen Senapathy, President

Sena@genome.com

   

1

     
  1.  

GenoMed

www.genomedics.com

Privately held

4560 Clayton Avenue

 

Saint Louis

MO

63110

USA

314.977.0115

 

David Moskowitz, Chairman and Chief Medical Officer

info@genomedics.com

   

0

No patents listed on website; provisional and patent applications to be listed

   
  1.  

Genomic Health Inc.

www.genomichealth.com

Privately held

   

Palo Alto

CA

 

USA

   

Randy Scott, CEO

Info@genomichealth.com

   

0

     
  1.  

Genomic Profiling Systems

 

Privately held

840 Memorial Drive

 

Cambridge

MA

02139

USA

617-547-7070

617-547-6060

Roanna London

roanna@genprosys.com

   

0

     
  1.  

Genomics Collaborative

www.dnarepository.com or

www.getdna.com

Privately held

99 Erie Street

 

Cambridge

MA

02139

USA

617-661-2400

877-436-6649

CEO ext. 2243

 

Michael Pellini, President

Mpellini@genecoop.com

   

0

Formerly Genomics Cooperative

   
  1.  

Genomics USA Inc.

 

Privately held

   

Houston

TX

 

USA

   

Rahul Mitra, President

     

0

     
  1.  

GenoPlex Inc.

www.evolgen.com

Privately held

6840 N. Broadway

Suite 200

Denver

CO

80021

USA

(303)429-5800

ext 13

(303)429-8608

Thomas E. Johnson, VP Functional Genomics

Tjohnson@genoplex.com

   

0

     
  1.  

Gen-Probe Inc.

www.gen-probe.com

Privately held

10210 Genetic Center Drive

 

San Diego

CA

92121-4362

USA

858-410-8000

800.523-5001

800-288-3141

Henry L. Nordhoff, President and CEO

ritam@gen-probe.com

   

140

     
  1.  

Gentris

www.gentris.com

Privately held

215 Southport Drive

Suite 300

Morrisville

NC

27560

USA

919-465-0100

919-465-0554

Michael P. Murphy, President and CEO

     

0

     
  1.  

Geospiza Inc.

www.geospiza.com

Privately held

3939 NW Leary Way

 

Seattle

WA

98107

USA

206-633-4403

206-633-4415

Todd Smith, President

info@geospiza.com

   

0

     
  1.  

Golden Helix Inc.

www.goldenhelix.com

Privately held

716 South 20th Street

Suite 102

Bozeman

MT

59718

USA

406-585-8137

406-522-1503

Christophe Lambert, Ph.D.

Info@goldenhelix.com

   

0

     
  1.  

HandyLab Inc.

www.handylab.com

Privately held

3985 Research Partk Drive

Suite 100

Ann Arbor

MI

48108

USA

734.663.7451

734.663.7437

Michael D. Farmer, President and CEO

infor@handylab.com

2000

INSTRMT, SUPPLYR

0

 

HP equity share

27jul02

  1.  

High Throughput Genomics Inc.

www.htgenomics.com

Privately held

6296 E. Grant Road

 

Tucson

AZ

85712

USA

520-547-2827

520-547-2837

Bruce Seligmann, President and CEO

info@htgenomics.com

1997

Instrmt, genexpr, supplyr

1 (rights to 2 others)

Purchased patent rights to NeoGen mNPA technology, Sort Combinatorial Chem from SIDDCO, and GenoMetriz Universal Array

Genomics spinoff of SIDDCO; Divested 2000 to Discovery Partners Intl.

27aug02

  1.  

Iconix Pharmaceuticals Inc.

www.iconixpharm.com

Privately held

850 Maude Avenue

 

Mountain View

CA

94043

USA

650-567-5500

650-567-5545

James Neal, CEO

     

0

     

332.   

ImgenexCorp.

www.imgenex.com

Privately held

11175 Flintkote Avenue

Suite E

San Diego

CA

92121

USA

888-723-4363

(858) 642-0978

(858) 642-0937

Sujay K. Singh, President and CEO

info@imgenex.com

ssingh@imgenex.com

   

0

     

333.   

Immusol Inc.

www.immusol.com

Privately held

10790 Roselle Street

 

San Diego

CA

92121

USA

(858) 824-1100

(858) 824-1112

Tsvi Goldenberg, CEO; Flossie Wong-Stahl, VP Genomics

info@immusol.com

   

4

     

334.   

Incogen (Institute for Computational Genomics)

www.incogen.com

Privately held

110 Liberty Drive

Suite 104

Clemson

SC

29631

USA

800-286-6599

864-654-0887

Maciek Sasinowski, CEO and President

Info@incogen.com

   

0

     
  1.  

Infinity Pharmaceuticals Inc.

www.infinitypharm.com

Privately held

650 Albany Street

 

Cambridge

MA

02118

USA

617.896.2901

617.859.9703

Steve Holtzman, President and CEO

Melanie Getchell

mgetchell@infinitypharm.com

2001

 

0

     
  1.  

InGenuity

www.ingenuity.com

Privately held

2160 Gold Street, 2nd Floor

PO Box 2199

Alviso

CA

95002-2199

USA

408-957-7777

408-957-7782

Jake Leschly, President and CEO

Info@ingenuity.com

   

0

     
  1.  

InPharmix Inc.

www.inpharmix.com

Privately held

PO Box 406

 

Greenwood

IN

46142

USA

317-422-1464

 

James P. Sluka, President

Jsluka@inpharmix.com

   

0

     
  1.  

Integrated Genomics

www.integratedgenomics.com

Privately held

2201 W. Campbell Park Drive

 

Chicago

IL

60612

USA

312-491-0846

312-491-0856

Robert Haselkorn, President and Chairman

     

0

     
  1.  

Invirion Inc.

www.invirion.com

Privately held

2350 Pilgrim Hwy

 

Frankfort

MI

49635

USA

231-352-6095

231-352-6510

Bruce Patterson, President

info@invirion.com

   

0

     

340.   

Iobion Informatics LLC.

www.iobion.com

Privately held

11011 North Torrey Pines Road

 

La Jolla

CA

92037

USA

877-852-1441

858-535-9930

512.321.3218

Jason Golcalves, CSO

info@iobion.com

2001

Infrmtx

0

   

27aug02

341.   

IP Genesis

www.ipgenesis.com

Privately held

   

Houston

TX

 

USA

(281) 419-9228

 

Aleksandar Milosavljevic, Founder

info@ipgenesis.com

   

0

Website notes US Patent # “6,001,562 and pending Patents”  That patent is assigned to University of Chicago (Argonne Natl Lab) and presumably licensed to IP Genesis.

Milosavljevic at Baylor Coll Med, previously Argonne Natl. Lab

 

342.   

LabBook Inc.

www.labbook.com

Privately held

8260 Greensboro Drive

Suite 100

McLean

VA

22102

USA

703-770-2800

703-288-5512

Shawn Gree, Chairman and CEO

Info@labbook.com

   

0

     
  1.  

LI-COR, Biotechnology Division

www.licor.com

Privately held

4421 Superior Street

PO Box 4000

Lincoln

NE

68504

USA

402-467-0700

800-645-4267

402-467-0819

       

4

     
  1.  

LifeSpan BioSciences Inc.

www.lsbio.com

Privately held

2401 Fourth Avenue

Suite 900

Seattle

WA

98121

USA

206-464-1554

206-464-1723

Joseph Brown, President and CEO

Gene@lsbio.com

1995

Drugdev, genefnl, genexpr

4

   

27aug02

  1.  

MacroGenics Inc.

www.macrogenics.com

Privately held

1500 East Gude Drive

 

Rockville

MD

20850

USA

301.251.5172

301.251.5321

Scott Koenig, President and CEO

Jeffrey Ravetch, Leroy Hood, Alan Aderem, and Ruedi Aebersold, cofounders

koenigs@macrogenics.com

   

0

     
  1.  

Mergen Ltd.

www.mergen-ltd.com

Privately held

14826 Wicks Blvd

 

San Leandro

CA

94577

USA

877.4MERGEN

877-463-7436

510-352-1988

510.352.6483

Qianjin Hu, President

     

0

     
  1.  

Metabolex Inc.

www.metabolex.com

Privately held

3876 Bay Center Place

 

Hayward

CA

94545

USA

510-293-8800

510-293-9090

Thomas A. Glaze, CEO

info@metabolex.com

   

0

     
  1.  

Microbia Inc.

www.microbia.com

Privately held

One Kendall Square

Building 1400W

Cambridge

MA

02139

USA

617-456-3600

617-494-0908

Peter M. Hecht, CEO

info@microbia.com

   

0

     
  1.  

MicroGenomics

www.microgenomics.com

Privately held

5935 Darwin Court

 

Carlsbad

CA

92008

USA

760-603-1286

760-603-1264

 

Info@microgenomics.com

   

0

     
  1.  

MitoKor Inc.

www.mitokor.com

Privately held

11494 Sorrento Valley Road

 

San Diego

CA

92121

USA

858-793-7800

858-793-7805

Walter H. Moos, CEO and chairman

moosm@mitokor.com

1996

Genemap, genefnl,

12

Website lists another 4 (non-DNA-based?) patents; purchased rights to Mimotope tech from Chiron in 2000; Acquired Apollo Therapeutics 2001

 

27aug02

351.   

Molecular Probes Inc.

www.molecularprobes.com

Privately held

4849 Pitchford Ave.

 

Eugene

OR

97402-9165

USA

(541) 465-8300

(541) 344-6504

Richard P. Haugland, President

     

22

     

352.   

Molecular Reflections

www.molecularreflections.com

Privately held

6330 Nancy Ridge Drive

Suite 107

San Diego

CA

92121

USA

858-623-0193

858-623-0331

Michael I. Nerenberg, President and CTO

Info@molecularreflections.com

   

0

     
  1.  

Molecular Staging Inc.

www.molecularstaging.com

Privately held

300 George St.

Suite 701

New Haven

CT

06511

USA

203-772-5000

203-776-5276

Torben Christensen, CEO

info@molecularstaging.com

   

1

     
  1.  

Mosaic Technologies

www.mostek.com

Privately held

1106 Commonwealth Ave.

 

Boston

MA

02215

USA

617-232-7636

617-232-7950

Michael Woehler, President and CEO

     

2

     
  1.  

Mycometrix

www.mycometrix.com

Privately held

213 East Grand Avenue

 

South San Francisco

CA

94080

USA

650.244.1419

650.244.1423

Gajus Worthington, President and CEO

gajus.worthington@mycometrix.com

   

0

 

Caltech startup

 
  1.  

Nanogen Inc.

www.nanogen.com

Privately held

10398 Pacific Center Court

 

San Diego

CA

92121

USA

858-410-4600

858-410-4848

Howard Birndorf, CEO

     

4

     
  1.  

NewcoGen (Applied Genomic Technologies)

www.newcogen.com

Privately held

150 Cambridge Park Drive

 

Cambridge

MA

02140

USA

617-497-2233

617-497-2244

Noubar Afeyan, CEO

Noubar.afeyan@newcogen.com

1999

TRSTFND

0

Applied Genomic Technologies one company under NewcoGen Group

   
  1.  

NimbleGen Systems LLC

www.nimblegen.com

Privately held

University Research Park

505 South Rosa

Madison

WI

53709-1257

USA

608-218-7620

 

Michael Treble, President and CEOr

info@nimblegen.com

   

0

 

Licensed technology from WARF (Univ Wisc)

 
  1.  

NuGEN

 

Privately held

821 Industrial Road

Unit A

San Carlos

CA

94070

USA

650-590-3600

650-590-3630

Jan d”Alvise, President and CEO

info@hugentechnologies.com

   

1

2001 patent

   
  1.  

NuTec Sciences, Life Sciences Division

www.nutecsciences.com

Privately held

1201 West Peachtree Street

Suite 800

Atlanta

GA

30309

USA

404-870-3300

404-870-3310

Anthony J. Shuker, President;

Michael H. Keehan, CEO

     

0

 

Collab with IBM & Emory: informatics

 
  1.  

Odyssey Pharmaceuticals Inc.

www.odysseypharma.com

Privately held

4550 Norris Canyon road

Suite 140

San Ramon

CA

94583

USA

925-242-1941

925-242-1936

Michael J. Powell, President and CSO; Anthony Carrano, Acting Director of Research

Mpowell@odysseypharma.com or info@odysseypharma.com

   

2

     
  1.  

OmniScience Pharmaceuticals Inc.

www.omniscience.com

Privately held

4665 S. Ash Avenue

Suite G-18

Tempe

AZ

85282-6764

USA

480-456-0145

480-456-0408

Michael Chaparian, President and CSO

     

0

     
  1.  

OmniViz Inc.

www.omniviz.com

Privately held

Two Clock Tower Place

Suite 600

Maynard

MA

01754

USA

978.461.1250

978.461.1299

Jeff Saffer, CTO and Acting President

support@omniviz.com

2000

INFRMTX

0

 

Spinoff from Battelle, March 2000

27aug02

  1.  

Oncotech Inc.

www.oncotech.com

Privately held

15501 Red Hill Avenue

 

Tustin

CA

92780

USA

(714) 566-0420

 

John P. Fruehauf, Medical Director

support@oncotech.com

   

0

     
  1.  

Ontogeny Inc.

www.ontogeny.com

Privately held

45 Moulton Street

 

Cambridge

MA

02138

USA

617-876-0086

617-876-0866

Doros Platika, President and CEO

     

2

     
  1.  

OriGene Technologies Inc.

www.origene.com

Privately held

6 Taft Court

Suite 300

Rockville

MD

20850

USA

301-340-3188

888-267-4436

301-340-9254

(would not give out name)

     

0

     
  1.  

Orion Genomics LLC

www.oriongenomics.com

Privately held

4041 Forest Park Blvd.

 

Saint Louis

MO

63108

USA

314-615-6977

314-615-6975

Richard Wilson, President and CEO

     

0

     

368.   

Pangene Corp.

www.pangene.com

Privately held

5500 Stewart Avenue

 

Freemont

CA

94538

USA

510-360-9100

510-360-9110

David Zarling, President and CEO

Info@pangene.com

   

1

Website lists 8 US and 5 WO patents

   
  1.  

Pangenomics Inc.

www.pangenomics.com

Privately held

6401 Foothill Blvd.

 

Tujunga

CA

94102

USA

818-353-5900

818-353-6500

Ung-Jin Kim, President and CEO

info@pangenomics.com

   

0

     

370.   

Peoples Genetics Inc.

www.peoplesgenetics.com

Privately held

6-C Gill Street

 

Woburn

MA

01801

USA

781.933.6068

781.933.8861

Kelley G. Murphy, President and CEO

     

0

     
  1.  

PharmaSeq Inc.

www.pharmaseq.com

Privately held

11 Deer Park Drive

Suite 204

Monmouth

NJ

08852

USA

732-355-0100

732-355-0102

Wlodek Mandecki, President and CEO

Mandecki@pharmaseq.com

   

0

     
  1.  

Phase-1 Molecular Toxicology Inc.

www.phase1tox.com

Privately held

2904 Rodeo Park Drive East

 

Santa Fe

NM

87505

USA

505.471.8438

505.471.8205

Vincent Kazmer, President and CEO

phase1@phase1tox.com

   

0

     
  1.  

Phylonix Pharmaceuticals Inc.

www.phylonix.com

Privately held

100 Inman Street

Suite 300

Cambridge

MA

02139

USA

617-441-6700

ext. 13 CEO

617-441-6766

George N. Serbedzija

George@phylonix.com

   

0

     
  1.  

Phylos Inc.

www.phylos.com

Privately held

128 Spring Street

 

Lexington

MA

02421

USA

(781) 862-6400

(781) 402-8800

Ashley Lawton, President

info@phylos.com

   

0

     
  1.  

Physiome Sciences Inc.

www.physiome.com

Privately held

307 College Road East

 

Princeton

NJ

08540-6608

USA

609-987-1199

609-987-9393

Jeremy Levin, CEO

Info@physiome.com

   

0

     
  1.  

Phytera Inc.

www.phytera.com

Privately held

377 Plantation Street

 

Worcester

MA

01605

USA

508.792.6800

508.792.1339

Malcolm Morville, President and CEO

info@phytera.com

   

0

     
  1.  

Plexxikon

www.plexxikon.com

Privately held

91 Bolivar Drive  

Suite A

Berkeley

CA

94710

USA

510-647-4000

510-548-8014

Peter Hirth CEO

info@plexxikon.com

   

0

     
  1.  

Pluvita Corp.

www.pluvita.com

Privately held

7315 Wisconsin Ave.

Suite 1000E

Bethesda

MD

20814

USA

301-907-0003

301-961-0264

Gary J. Kurtzman, CEO

webmaster@pluvita.com

   

0

 

acquired Diogenics Oct 2002

 
  1.  

Praelux Inc.

Www.praelux.com

Privately held

17 Princess Road

 

Lawrenceville

NJ

08648

USA

609-620-0220

609-620-0222

David Livingston, President and CEO

     

0

Formerly SeQ, Ltd.

   
  1.  

Premier Biosoft Internatoinal

www.premierbiosoft.com

Privately held

3786 Corina Way

 

Palo Alto

CA

94303-4504

USA

650-856-2703

650-843-1250

       

0

     

381.   

ProCeryon Biosciences Inc.

www.proceryon.com

Privately held

309 West 82nd Street

 

New York

NY

10024

USA

212-595-1102

212-595-1156

Alessandro Monge, President and CEO

     

0

See also ProCeryon GmbH of Austria; ProCeryon renamed from King’s Beech Biosoftware

   

382.   

Prolinx Inc.

www.prolinxinc.com

Privately held

22322 20th Avenue SE

 

Bothell

WA

98021

USA

425-487-3401

425-487-9578

James E. Mahoney, President and CEO

info@prolinxinc.com

   

2

     
  1.  

Protedyne

www.protedyne.com

Privately held

1000 Day Hill Road

 

Windsor

CT

06095

USA

860.683.1860

860.683.4178

Stan Klein, President

info@protedyne.com

2000 or before

Genefnl, genexpr

0

 

Instrumentation

 
  1.  

Protein Pathways, Inc.

www.proteinpathways.com

Privately held

Suite 304

1145 Gayley Avenue

Los Angeles

CA

90024

USA

310-208-8444

310-208-8004

Todd Yeates, Interim President;

Larry Souza, Chairman and founder

Jkelly@proteinpathways.com, business development

   

0

     
  1.  

Protogene Laboratories Inc.

www.protogene.com

Privately held

303 Constitution Drive

 

Menlo Park

CA

94025

USA

650-289-2900

650-289-2910

Christopher R. Wolf, President and CEO

     

1

     
  1.  

Psychiatric Genomics Inc.

www.psygenomics.com website not operating 4/5/01 placeholder site at

www.fkhealth.com/psychgenpress2.html

Privately held

19 Firstfield Road

 

Gaithersburg

MD

20878

USA

301-556-1310

301-556-1317

310-556-1350

Richard E. Chipkin, CEO

Michael G. Palfreyman, President and CEO

Mpalfreyman@psygenomics.com or mpalfreyman@aol.com

   

0

     
  1.  

QIK Technology

www.qiktechnology.com

Privately held

PMB 305

423 Brookline Avenue

Boston

MA

02215

USA

617-584-7869

 

Samuel E. Driver, President

Info@qiktechnology.com

   

0

     
  1.  

Quark Biotech Inc.

www.quarkbiotech.com

Privately held

10265 Carnegie Avenue

 

Cleveland

OH

44106

USA

800-730-5795

206.791.6114

216.791.6115

Daniel Zurr, President and CEO

laorb@qbius.com

1993

GENEFNL, PHRMGEN, GENEXPR

DRUGDEV

1

 

US-Israel company IPO announced 2000, but not completed

30jul02

  1.  

Radius Biosciences Inc.

www.ultranet.com/~radius

Privately held

Box 22

 

Medfield

MA

02052

USA

508-359-8828

508-359-2940

       

0

     
  1.  

Renovis

www.renovix.com

Privately held

270 Littlefield Avenue

 

South San Francisco

CA

94080-6924

USA

650-266-1400

650-266-1460

Corey Goodman, President and CEO

publicrelations@nenovix.com

   

0

     

391.   

RHeoGene LLC

www.rheogene.com

Privately held

706 Forest Street

 

Charlottesville

VA

22903

USA

804-220-3333

804-975-4301

Mohan Philip, CSO

Info@rheogene.com

   

0

     
  1.  

Rubicon Genomics Inc.

www.rubicongenomics.com

Privately held

370 Varsity Drive

 

Ann Arbor

MI

48108

USA

734.677.4845 x.131

734.368.1705 cell

 

Thomas Collet, CEO

collet@rubicongenomics.com

2000

 

0

     
  1.  

Sagres Discovery

www.sagresdiscovery.com

Privately held

2795 Second Street

Suite 400

Davis

CA

95616

USA

530.297.4700

530.297.4701

David Ferrick, CEO

info@sagresdiscovery.com

2000

Genefnl, drugdev

0

 

UCDavis spinoff; oncogene discovery and drug development

27aug02

  1.  

Scion Pharmaceuticals Inc.

www.scionpharma.com

Privately held

200 Boston Avenue

Suite 3600

Medford

MA

02155

USA

781-391-1900

781-306-0800

Pravin R. Chaturvedi, President and CEOr

info@scionpharma.com

   

0

     
  1.  

SciTegic Inc.

www.scitegic.com

Privately held

4540 Kearny Villa Road

Suite 224

San Diego

CA

92123-1587

USA

858-573-8410

858-573-8412

Mathew Hahn, President and CEO

Support@scitegic.com

   

0

     
  1.  

Selective Genetics

www.selectivegenetics.com

Privately held

11035 Roselle Street

 

San Diego

CA

92121

USA

858-625-0100

619-625-0050

Andrew Baird, CSO

Info@selectivegenetics.com

   

0

     
  1.  

Senomyx Inc.

www.senomyx.com

Privately held

11099 Torrey Pines Drive

 

La Jolla

CA

92037

USA

(858) 646-8300

(858) 404-0752

Paul Grayson, CEO

Jean.lockhart@senomyx.com

   

0

Licensing agreements with Rockefeller, Harvard, Johns Hopkins, U Calif on olfactory and vomeronasal receptor and related genes; company focus is flavor and fragrance molecules

   
  1.  

Sequitur Inc.

www.sequiturinc.com

Privately held

14 Tech Circle

Suite 210

Natick

MA

01760

USA

508-650-1459

ext. 2 Tech VP

508-650-1625

Tod Woolf, VP for technology development

Twoof@sequiturinc.com

   

0

     
  1.  

SeqWright

www.seqwright.com

Privately held

2472 Bolsover

Suite 425

Houston

TX

77005

USA

(713) 528-4363

(800) 720-4363

(713) 528-6232

Fei Lu, Head of Genotyping Dept

     

0

     
  1.  

Signature BioScience

sig.cncoffice.com/index.html

Privately held

21125 Cabot Boulevard

 

Hayward

CA

94545

USA

510 576 2334

510 576 2434

Mark McDade, CEO

Info@signaturebio.com

   

0

     
  1.  

Silicon Genetics

www.sigenetics.com

Privately held

935 Washington Street

 

San Carlos

CA

94070

USA

650-591-4459

650-591-5574

Andrew Conway, CEO

Info@sigenetics.com

   

0

     
  1.  

Softberry inc.

www.softberry.com

Privately held

108 Corporate Park Drive

Suite 120

White Plains

NY

10604

USA

(914) 253-8740

(914) 253-9224

 

Softberry@softberry.com

   

0

     
  1.  

Spectral Genomics Inc.

www.spectralgenomics.com

Privately held

8080 North Stadium Drive

Suite 2200

Houston

TX

77054

USA

713-797-1000

713-797-0203

Shishir Shah, Principal Scientist

Sshah@spectralgenomics.com or info@spectralgenomics.com

   

0

     
  1.  

Spotfire

www.spotfire.com

Privately held

60 Hampshire Street

 

Cambridge

MA

02139

USA

800-245-4211

617-621-0340

617-621-0381

Bill Ladd, Director of Bioinformatics

Bill.Ladd@spotfire.com

   

0

     
  1.  

Structural GenomiX

www.stromix.com

Privately held

10505 Roselle Street

 

San Diego

CA

92121

USA

858-558-4850

858-558-4859

Tim Harris, CEO and President

Tim@stromix.com

   

0

     
  1.  

Structure Function Genomics

www.monmouth.com/~spidersigns/SFG

Privately held

125 Springdale Road

 

Princeton

NJ

08540

USA

609-497-9093

 

Stephen Anderson, CEO

Anderson@mbcl.rutgers.edu

   

0

     
  1.  

Sunol Molecular Corp.

www.sunolmolecular.com

Privately held

2810 North Commerce Parkway

 

Hollywood

FL

33025-3958

USA

954-443-8600

954-443-8610

Hing Wong, President and CEO

     

2

     
  1.  

Super Array Inc.

www.superarray.com

Privately held

P.O. Box 34494

 

Bethesda

MD

20827-0494

USA

(301) 765-9888

(301) 765-9859

Li Shen, President

Info@superarray.com

   

0

     
  1.  

TeleChem International Inc.

Arrayit.com

Privately held

524 E. Weddell Drive

Suite 3

Sunnyvale

CA

94089

USA

408-744-1331

408-774-1711

Rene A. Schena, President

Arrayit@arrayit.com

   

0

     
  1.  

TissueInformatics Inc.

www.tissueinformatics.com

Privately held

711 Bingham Street

“Achieva” Building

Pittsburgh

PA

15203

USA

412.488.1100

412.488.6172

Peter C. Johnson, Chairman and CEO

Dennis S. Meteny, President and COO

     

0

     
  1.  

TurboGenomics Inc.

www.turbogenomics.com

Privately held

One Century Tower

265 Church Street

New Haven

CT

06510

USA

203-974-0470 ext 231

203-776-4074

Gregory Gardiner, President and CEO

Ssherman@turbogenomics.com VP operations

   

0

     
  1.  

US Genomics

www.usgenomics.com

Privately held

6H Gill Street

 

Woburn

MA

01801

USA

(781) 937-5550

781-938-0060

Eugene Chan, CEO

Info@usgenomics.com

   

0

     
  1.  

Viaken Systems Inc.

www.viaken.com

Privately held

16 South Summit Avenue

Suite 250

Gaithersburg

MD

20877

USA

301-216-3400

301-330-6950

Keith Elliston, President and CEO

Keith.elliston@viaken.com or info@viaken.com

   

0

     
  1.  

Virtual Array

 

Privately held

1033 Tulipan Drive

 

San Jose

CA

95129

USA

           

0

     
  1.  

Xanthon Inc.

www.xanthoninc.com

Privately held

104 Alexander Drive

Building 5

Research Triangle Park

NC

27709-2296

USA

919-572-0707

919-547-3723

Neil Moore, Interim CEO

     

1

 

Announced cutting half of staff April 2002.

 
  1.  

Xenogen

www.xenogen.com

Privately held

860 Atlantic Avenue

 

Alameda

CA

94501

USA

510-291-6100 or 888-810-8055

510-291-6196

David W. Carter, Chair and co-CEO; Pamela A. Contag, President and co-CEO

Info@xenogen.com

   

0

 

IPO registered, but withdrawn April 2000

 

417.   

Xeotron Corp.

www.xeotron.com placeholder site 4/5/01

Privately held

8285 El Rio

Suite 130

Houston

TX

77054

USA

713-842-2151

713-842-9060

X. Chuan Zhou, President

Xczhou@Xeotron.com

   

0

     

418.   

X-MINE Inc.

www.x-mine.com

Privately held

1000 Marina Blvd.

Suite 450

Brisbane

CA

94005

USA

650.829.2600

650.829.2647

Sandip Ray, President and CEO

info@x-mine.com

   

0

     

419.   

Zerosum Inc.

www.zerosum.com

Privately held

1060 Brighton Drive

 

Seven Valleys

PA

17360

USA

800-672-2899

717-428-9744

 

John W. Sherwood, CEO

zerosum@netrax.net

   

0

     

420.   

Zygogen LLC

www.zygogen.com

Privately held

520 Kell Hall

24 Peachtree Center Avenue

Atlanta

GA

30303

USA

404-523-7309

404-523-5974

Nina Sawczuk, CEO

Info@zygogen.com

   

0

     
  1.  

Celestar Lexico-Sciences

www.cl-sciences

Privately funded

D-17, Makuhari Techno-Garden

1-3, Nakase

Mihama-ku

Chiba

261-8501

Japan 

   

Hisayuki Horai

horai@cl-sciences.co.jp

           
  1.  

454 Corporation

www.454.com

Private (majority-owned subsidiary of Curagen)

555 Long Wharf Drive

11th Floor

New Haven

CT

06511

USA

203-401-3330

203-401-3337

Richard F. Begley, President and CEO

454@curagen.com

2000

 

0

 

Majority-owned subsidiary of Curagen

 
  1.  

MetriGenix Inc.

www.metrigenix.com

Pivately held

708 Quince Orchard Road

 

Gaithersburgh

MD

20878

USA

301-987-1722

301/987-1716

301-987-1717

Andrew O'Beirne, President and CEO

aobeirne@metrigenix.com

2001

 

(3)

Website notes Gene Logic patent of 1998 seminal to MetroGenix technology

Spun off from Gene Logic July 2001

 
  1.  

Psynomics Inc.

 

Pirvately held

   

San Diego

CA

               

0

 

5% owned by Global Genomics Capital

 
  1.  

EmerGen

www.emergenlabs.com

Pirvately held

390 Wakara Way

 

Salt Lake City

UT

84108

USA

888.343.1338

801.883.0103

801.882.0110

Richard Jackson, President and CEO

mmeade@emergenlabs.com

   

0

     
  1.  

MolecularWare

www.molecularware.com

Pirvately held

7 Temple Street

 

Cambridge

MA

02139

USA

617-354-9797

617-

Richard P. Kivel, CEO

info@molecularware.com

   

0

     

427.   

Genome Quebec

www.genomequebec.com

Nonprofit

McGill University

 

Montreal

Quebec

 

Canada

   

Paul L’Archeveque, President and CEO

agravel@genomequebec.com or info@genomequebec.com

   

0

 

Provincial arm of Genome Canada, a nonprofit organization.  Seed funding from Genome Canada with additional funding from Quebec Ministry of Research.

 
  1.  

Genset SA

www.genxy.com

Acquired by Serono

(GENXY)

24, rue Royale

 

75008 Paris

   

France

+33 1 55 04 59 00

+33 1 55 04 59 29

Marc Vasseur, CEO

Daniel Cohen, Chief Genomics Officer

Daniel.cohen@genset.fr

   

14

 

Acquired by Serono June 2002

 
  1.  

Compugen Ltd.

www.cgen.com

Acquired by Norigen

72 Pinchas Rosen Street

 

Tel Aviv

 

69512

Israel

972-3-765-8585

972-3-765-8555

Mor Amitai, CEO

Eli Mintz, Presidnet

Info@cgen.com

1993

 

0

 

IPO Aug 2000; Acquired by Norigen Sept 2000

 
  1.  

Research Genetics Inc.

www.resgen.com

Acquired by Invitrogen Feb 2000

2130 Memorial Parkway SW

 

Huntsville

AL

35801

USA

800-533-4363

256-536-9016

James R. Hudson, founder

Info@resgen.com

     

Acquired by Invitrogen 2/2001

   
  1.  

Genomic Solutions

www.genomicsolutions.com

Acquired by Harvard BioSciences

4355 Varsity Drive

 

Ann Arbor

MI

48108

USA

(734)975-4800 or 877-genomic

(734)975-4808

Jeffrey S. Williams, CEO

Info@genomicsolutions.com

   

1

 

Acquired by Harvard Bioscience (HBIO) July 2002

27jul02

  1.  

Visible Genetics

www.visiblegenetics.com

Acquired by Bayer

700 Bay Street

Suite 1000

Toronto

Ontario

M5G 1Z6

Canada

416-813-3240

416-813-3250

Richard Daly, President and CEO

Info@visgen.com

 

PHRMGEN

30

 

Acquired by Bayer July 2002

27jul02